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      1. INTRODUCTION 
All over the world traditional systems of medicine have become significantly 
more popular because of the curative property, less toxic and minimal side effects. 
Siddha medicine is a unique one as it is not only a curative but also preventive and to 
achieve the healthy body and mind. Siddha medicines revitalize and rejuvenate the 
body. It is well known that all the eyes of the world are turning to the natural 
medicine, especially indigenous system of medicine to find out a more acceptable 
drug for incurable diseases. 
 All Indian systems of medicine use plants, minerals and animal products as 
main ingredient to cure various ailments. It is more widely used for the human 
ailments from time immemorial. The mode of preparation and plant used in traditional 
medicine varies from place to place. Siddha system of medicine is the oldest holistic 
management system with meticulously documented medicines and being practiced by 
a large population in south India.  
Siddhars believed that there is a connection between the external world and 
the internal world, which is universe as macrocosm and human as microcosm. Any 
change in the external world brings changes in man.
1
 It is quoted by the great Siddhar 
Sattamuni as  
 
mz;lj;jpy; cs;sNj gpz;lk; 
gpz;lj;jpy; cs;sNj mz;lk; 
mz;lKk; gpz;lKk; xd;Nw 
mwpe;Jjhd; ghHf;Fk; NghNj    
    -rl;lKdp ehjH 
 
The volumes of literatures in Siddha system of medicine describes about 4448 
diseases. Apart from the usage of herbs, it could assert that the Siddhars were the 
pioneers in the use of minerals, metals and animals in the treatment of diseases.  
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Saint Thirumular, the one among eighteen siddhars define medicine as follows  
 
kWg;gJ cly; Neha; kUe;njd yhFk; 
kWg;gJ csNeha; kUe;njdr; rhYk; 
kWg;gJ ,dpNeha; thuh jpUf;f 
kWg;gJ rhit kUe;njd yhNk. 
 According to Thirumular, the above lines can be explained as medicine means 
one that ensures physiotherapy, psychotherapy, prevention and prevention against 
untimely mortality.
2 
Respiratory diseases such as asthma and chronic obstructive pulmonary 
disease (COPD) are a serious health problem, which are increasing rapidly 
worldwide. The current therapy has its own shortcomings and notable adverse effects.  
‘Asthma’ is a Greek word which means ‘breathless’ or ‘to breathe with open 
mouth’. Bronchial asthma is an important allergic disorder and it is defined as ‘a 
chronic inflammatory disorder of the airways associated with increased airway hyper-
responsiveness, recurrent episodes of wheezing, breathlessness, chest tightness, and 
coughing, particularly at night/early morning. It can be triggered by various factors 
like allergens, drugs, respiratory infection, dust, cold air, exercise, emotions, 
occupational stimuli, chemicals, histamine and also hereditary. The incidence of 
bronchial asthma is increasing nowadays. Prevalence of asthma is between 100 and 
150 million people around the globe and India has an estimated 15-20 million 
asthmatics. The prevalence of current asthma was 11.9% in children. Allergies in 
Childhood (ISAAC) have provided data on asthma prevalence in 6-7 and 13-14 year 
old Indian children
3
.The above findings indicate that the burden of bronchial asthma 
in Indian children is higher. In chronic asthmatics, the aim is to prevent 
bronchospasm. 
The World Health Organization recognizes Asthma is a disease of major 
public health importance and place a unique role in the co-ordination of international 
efforts against the disease. The drugs like Bronchodilators, Anti inflammatory agents,  
Mast cell stabilizers, LT receptor antagonists are used for Bronchial asthma all over 
the world. Both prevention of inflammatory response and bronchial hyperactivity are 
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important for the long term control of asthma. Despite the availability of a wide range 
of Anti-asthmatic drugs, the relief offered by them is mainly symptomatic and short 
lived with more or less side effects.  
 In Siddha system the symptoms of Bronchial asthma can be correlated with 
the symptoms of Swasakasam as quoted by Yugi muni 
4
. In other system of medicine, 
three different drugs such as bronchodilators, anti inflammatory and sometimes anti 
pyretic were used for the management of bronchial asthma. But in our siddha system, 
single formulation can be used for the treatment of bronchial asthma which has all 
these properties.  Many herbal, herbo-mineral and animal origin formulations which 
has bronchodilator, mast cell stabilizer, and anti – inflammatory activity are used for 
the treatment of bronchial asthma (Swasa kaasam).  
Poonaga parpam is an animal origin siddha formulation which is quoted in the 
text “Sikicha Rathina Deepam” that is indicated for bronchial asthma5. It is a fine ash 
obtained through incineration. Poonagam (earthworm) and Aaduthinnapaalai 
(Aristolochia bracteata) are used as an ingredient for the preparation of Poonaga 
parpam . It is prepared through the special oxidation procedure involving purified 
form of earthworm processed under herbal juice. This trial drug has been used for the 
management of bronchial asthma by traditional healers and siddha physicians and 
there is also scientific data for its safety.  
Siddha system which has got a hoary of antiquity is based on five elemental 
Theory (Pancha Pootha Theory). The therapeutic potency of any drug were designed 
depending on the following parameters namely 
 Suvai 
 Gunam 
 Veeriyam 
 Vibhaham6 
In siddha system of medicine there is an interrelation between veeriyam and 
treatment.  All the raw drugs that is Poonagam (earthworm) and Aaduthinnapaalai 
(Aristolochia bracteata)  and the finished medicine Poonaga parpam , a nano sized 
formulation possesses veppa veeriyam which is mainly related to the treatment of 
Bronchial asthma. 
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Standardization of Siddha preparations is an important task in establishing the 
safety and efficacy of the drug .The World Health Organization (WHO) guidelines on 
evaluating the physicochemical properties and other parameters for the identification 
of AYUSH formulations which will offer a great value in global market. 
Standardization ensures the quality of medicines and gives authenticity to the 
medicines prepared by the manufacturers, satisfaction of the prescribing physicians 
and relief to the consumers. Characterization of Siddha formulation renders wide 
range of information in predicting the nature and structure of phyto constituents which 
renders the actual therapeutic efficacy of the formulation.   
So the Researcher chosen this formulation for the standardization by analyzing 
the physicochemical properties, chemical analysis, elemental analysis and screening 
the pharmacological activities of Bronchodilator, Anti inflammatory and Anti pyretic 
activities on animal model.  
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2. AIM AND OBJECTIVES 
Aim 
          To Standardize and evaluate the pharmacological profile of the test drug            
"Poonaga Parpam" in a animal model. 
Objectives 
The following methodology was adopted to Standardize and evaluate the 
pharmacological activity of the test drug: 
 
 Collection of various information relevant to the study which include Siddha and 
Modern aspect of drug, pharmacological and pharmaceutical review. 
 Identification of raw drugs in Poonaga Parpam. 
 Preparation of Poonaga Parpam as per classical Siddha literature. 
 Standardization of test drug 
 To standardize the drug through physicochemical analysis. 
 To analyze the drug chemically for detection of acid, basic radicals and 
heavy metals. 
 To estimate the percentage of elements, functional groups and particle 
size through Instrumental analysis of the trial drug. 
 
 To determine the following pharmacological activities  
 
 Bronchodilator activity by Histamine induced Bronchoconstriction in 
Guinea pig model. 
 Anti-inflammatory activity by Carrageenan-induced rat paw edema in 
Wistar albino rat model. 
 Antipyretic activity by Brewer’s Yeast induced method in Wistar 
albino rat model. 
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 3. MATERIALS AND METHODS 
 
Standard Operative Procedure for preparation of “Poonaga parpam”5 
The test drug Poonaga parpam, mentioned in Siddha text “Sikicha Rathina 
Deepam”, 2007 edition, pg no 232, has been used for Kodiya Kaasam (Asthma), 
Mega Suram (Syphilitic Fever), Thagam (Thirst). 
The ingredients of this formulation are 
 1. Purified Poonagam (Earthworm)    1 Veesai (1400gm) 
 2. Juice of Aduthinna paalai (Aristolochia bracteata) 1 litre 
 3. Butter milk       3 litres 
Collection of Raw Drugs: 
The poonagam (Earthworm) and Aduthinna paalai (Aristolochia bracteata) 
was collected from in and around Thanjavur district, Tamilnadu. All the ingredients 
were purified and the medicine was prepared in the Gunapadam laboratory of 
National Institute of Siddha. 
Identification and Authentication of the drug: 
The poonagam (Earthworm) was identified and authenticated by competent 
authority of Gunapadam Department, National Institute of Siddha, Tambaram 
sanatorium, Chennai.  
Aduthinna paalai (Aristolochia bracteata) was identified and authenticated by 
Botanist, Department of Gunapadam, National Institute of Siddha, Tambaram 
sanatorium, Chennai.   
Purification (Suddhi ) 
5,7,8
: 
The earth is considered to be a source of valuable drugs. Earthworms not only 
enriched with pharmaceutically useful compounds but also contain certain toxic 
materials. One of the most important tasks is removal of these toxic substances, which 
is called purification (Suddhi) of raw materials by Siddhars. Otherwise it may results 
in toxicity. Suddhi contributes the following changes in the raw drug: 
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 Reduction in particle size 
 Conjugation of trace elements 
 Elimination of unwanted elements 
 Formation of desirable compounds 
Poonagam 
Poonagam was soaked in buttermilk. When it repels the sand it was taken out 
and dried, then it was grounded.   
Aduthinna paalai 
Aduthinna paalai was washed in the running tap water to remove the soil and 
impurities. 
Preparation of Poonaga parpam: 
Procedure: 
Purified Poonagam was grounded well using mortar and pestle and juice of 
Aduthinna Paalai (Aristolochia bracteolata) was added little by little to it for one day 
and made into pellet and dried. The pellet was then placed in between two earthen 
saucers and it was covered by mud sealed cloth. Then it was subjected into pudam by 
using 100 cow dung cakes. The above mentioned procedure was repeated for 9 times 
and finally the parpam was powdered well and stored in an air tight container. 
Labelling:   
Name of the preparation : Poonaga parpam 
Dose :       ½ - 1Kundri(65-130 mg) Twice daily 
Adjuvant/Vehicle : After food with Honey          
Route of administration : Oral 
Indications : Kodiya Kaasam (Asthma) 
       Mega Suram (Syphilitic Fever) 
Date of expiry : 100 years from the date of manufacture 
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       INGREDIENTS OF POONAGA PARPAM 
 
                          
         Fig.No.1 Poonagam (Earthworms)  
 
 
           Fig.No.2 Aaduthinna paalai (Aristolochia bracteata) 
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                           Fig.No.3 Mud Sealed Earthen Saucer             
                                                                  
              Fig.No.4.1                                                    Fig No.4.2 
                                  
                Fig.No.4.3                                                 Fig.No.4.4                         
                      Fig.No.4 Pudam process 
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           Fig.No.5  Poonaga parpam 
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      4. REVIEW OF LITERATURE 
4.1 GUNAPADAM REVIEW 
Poonagam (Earthworm)
9 
It is mostly available in slough. In Siddha aspect, there are two varieties of 
earthworms i.e.,reddish and pale red coloured.  
Reddish earthworms have great medicinal values because of its more copper 
content. 
Synonym 
 Naankuzh Pulu 
 Naaku Poochi 
 Kandapadham 
 Boomiver 
General characteristics of Poonagam  
khjtW nra;twl;rp khWklq; fhr;re;ep 
ghjtW NehNahL ghWkly;- thjthW 
Fz;lgjkPS Nkhf;fhs ikaKk;Nghq; 
fz;l gjnkd;Dq; fhy; 
 
- Pathartha Guna Sinthamani 
Action 
It is mainly used to treat severe thirst, crural paralysis (paralysis of the thighs 
characterized by loss of motion and sensation arising from the deranged condition of 
wind humor in the lower part of the body), vomiting and phlegmatic diseases. 
Purification  
 The earthworms can be taken out after soaking it in milk or buttermilk. If the 
lime water is poured on the earthworms, they will die. 
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Medicinal uses 
 The purified and dried earthworms are made into chooranam form. 12.6 gm 
of the chooranam along with grape juice used for the treatment of retention 
of urine and calculus in the urinary tract. 
 When it is given in non – vegetarian soup, it improves sperm production. 
 When applied topically with almond ghee, it will reduce hernia. 
 When it is given internally with boiled gingelly oil, it cures chronic cough 
and throat pain. 
 When it is ground raw and applied topically the nerves which are cut will 
regenerate. When ground with black stone and applied topically, it will 
correct the dislocation of joints. It will also dissolve the blood clot caused by 
injury. 
 The earthworm is fried in gingelly oil along with equal quantity of dried 
leech. It is then applied over the penis for improving the sexual vigour. 
 When the earthworm is used for medicinal purposes, ghee, milk, and meat 
should be taken in excessive quantities. 
Siddha formulations using Poonagam as ingredient 
 Poonaga chenduram 
 Poonaga Karukku 
 Poonaga Karukku Kudineer 
 Seenthil Chooranam 
 Poonaga Chooranam 
 Thanga Chenduram 
 Varmaani Kuligai 
 Nava Paasana Poonaga Ennai 
 18 Kirigaikkum Kulambu 
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AADUTHINNA PAALAI – Aristolochia bracteata10,11 
Synonym 
 Aadu theenda paalai 
 Aadu thodappalai 
 Pangampaalai  
Parts Used 
 Leaves, seed, root or whole plant  
Organoleptic Characters 
 Taste        :  Bitter  
Character : Heat 
Division  : Acrid 
Action 
 Anthelmintic 
 Emmenogogue 
 Stimulant 
 Tonic 
 Purgative 
 Alterative 
 Anti periodic 
General characteristics of  Aaduthinnapaalai 
fpue;jpfug; gd;ntf;if Nfreyp khe;ij 
aue;ij tpidia aWf;Fk;- Jwe;J 
gpupnahzh Neha;fisAk; gpd;Kd;ghuhky; 
kwpAzh KPypail tha;   -Theraiyar Venba 
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MLnjhlhg; ghisf; fff;fUkp td;rpye;jp 
ePLfUq; Fl;lk; epiwfug;ghd;- Mblr;nra; 
vz;gJ tha;Tk; ,fy;Fl;l Ke;jPUk; 
jpz;ngWew; whJTkhQ; nrg;G. 
      -Agathiyar Gunavakadam 
 It cures skin eruptions, glandular swelling, hair loss, congenital heat in 
children. It also Cures intestinal worms infestations, ringworms, 80 types of vadha 
diseases. 
  
Medicinal Uses: 
 The decoction of the leaves  is given for above mentioned ailments. 
 The powdered seed along with castor oil can be used to cure stomach ache,  
amenorrhoea, intermittent fever, labour pain. It also cures intestinal worm 
infestations. 
 The whole plant along with gingelly oil can be used externally to cure 
ringworm, eczema. 
 The powdered root is used to cure snake bites and other poisonous bites. 
 
Siddha formulations using  Aaduthinnapaalai  as ingredient 
 Aadutheendapaalai Ennai 
 Thuvar Ennai 
 Mooku Noi Thailam 
 Aadutheendapaalai Maathirai 
 Milagennai 
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4.2 ZOOLOGICAL REVIEW 
   EARTHWORMS  
Earthworms are macroscopic clitellate oligochaete annelids that live in soil. It 
is the common name for certain terrestrial members of the class Oligochaeta, 
especially forms belonging to the family Lumbricidae. 
Vernacular names 
 Tamil   : Poonagam/ Manpuzhu 
 English   : Earthworm / Red worm/night walker 
 Sanskrit  : Bhūjantuḥ  
 Telugu   : Vānapāmu 
 Kannada  : Mannuhulu  
 Malayalam  : Maṇṇira 
 Hindi   : Kenchua 
 Gujarathi   : Aḷasiyā 
 Bengali  :   m    
 Urdu    : Kechwa 
Scientific Classification 
Kingdom :  Animalia 
Phylum :  Annelida 
Class  : Oligochaeta 
Subclass : Oligochaeta 
Order  : Megadrilacea 
Suborder : Lumbricina + Moniligastrida 
Characters & Description
12
  
 There are 2,200 earthworm species, found all over the world except in arid and 
arctic regions and ranging in size from 1 in. (2.5 cm) to the 11-ft (330-cm) 
giant worms of the tropics. Some earthworms are pallid in color, many are 
reddish brown to purple, and one Philippino species is bright blue.  
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 Earthworms burrow in the ground, swallowing soil from which the organic 
material is extracted and ground up in the gizzard and depositing the residue 
as castings outside the burrow. They come to the surface only on cloudy days 
and at night (hence the name night crawlers) unless they are flooded out by 
heavy rainfalls. In cold and dry weather they retreat into their burrows and 
remain dormant. 
 The segments of the earthworm, visible externally as rings, are separated by 
internal partitions. On each segment are four pairs of bristles, or setae, with 
which the worm anchors it selves to the walls of the burrow, drawing itself 
forward by rhythmic muscular contractions. There is a nerve cord, with 
ganglia in each segment and an enlarged cerebral ganglion (a primitive brain) 
at the anterior end. Although they have no prominent sense organs, 
earthworms are sensitive to light, touch, vibration, and chemicals.  
 The circulatory system is enclosed in vessels; the blood (which contains 
haemoglobin) is pumped by muscular contractions of five linearly arranged 
hearts. 
 Earthworms are hermaphroditic, but they cross-fertilize. Two worms exchange 
sperm cells during copulation; fertilization occurs after the worm's own eggs 
and the received sperm are encased in a tough sheath secreted by the clitellum, 
a conspicuous band of tissue near the anterior end. The sheath slips over the 
worm's head and is deposited underground, where it serves as a cocoon for the 
developing young. There is no larval stage; the young hatch as miniature 
adults.  
 The common American and European earthworm, Lumbricus terrestris, up to 
10 in. (25 cm) long, with about 150 segments, is used for laboratory dissection 
and study. 
 Earthworms are also used as live bait and are eaten by some peoples—such as 
the Maoris, who consider certain species delicacies.  
 The earthworm's greatest service, however, of immense importance to 
agriculture, is aerating and mixing the soil. Earthworm castings bring to the 
surface from 7 to 18 tons of soil per acre annually.  
 Earthworms(L.rubellus) plays an important role in human life because of its 
high nutrient content, especially protein (64-76%). 
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Ecology
13 
Earthworms are classified into three main Eco physiological categories:  
(1) Leaf litter- or compost-dwelling worms that are non-burrowing, live at 
soil-litter interface and eat decomposing OM (called Epigeic) e.g. Eisenia fetida;  
(2) Topsoil or subsoil-dwelling worms that feed (on soil), burrow and cast 
within soil, creating horizontal burrows in upper 10–30 cm of soil (called Endogeics); 
and  
(3) Worms that construct permanent deep vertical burrows which they use to 
visit the surface to obtain plant material for food, such as leaves (called Anecic which 
means "reaching up"), e.g. Lumbricus terrestris. 
Earthworms form the base of many food chains. They are preyed upon by 
many species of birds (e.g. starlings, thrushes, gulls, crows, European robins and 
American robins), snakes, mammals (e.g. bears, foxes, hedgehogs, pigs, moles) and 
invertebrates (e.g. ground beetles and other beetles, snails, slugs). Earthworms have 
many internal parasites, including protozoa, platyhelminthes, and nematodes; they can 
be found in the worms' blood, seminal vesicles, coelom, or intestine, or in their 
cocoons. 
Action 
 Antioxidant 
 Antiulcer 
 Hepato-protective  
 Anticancer 
 Anti Pyretic 
 Anti Inflammatory 
 Wound healing   
 Fibrinolytic/fibrinogenolytic,  
 Thrombolytic and anti-coagulative Activity. 
Earthworms have been used as a traditional medicine in China, Japan and the 
other Far East countries for thousands of years. Extraction and purification of the 
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bioactive material contained in the protein earthworms have been conducted in 
various countries. 
 Nutritional Profile of Earthworm Powder of Lampito mauritii. 
 Carbohydrate      4.1 %  
 Protein      31.7 % 
 Nitrogen      1.83% 
 Phosphorus     0.38%  
 Potassium    0.53% 
 Iron     241.1 (ppm) 
 Magnesium     0.213(ppm)   
 Manganese      17.2 (ppm)  
 Zinc      32.34 (ppm)  
 Copper      4.50(ppm)  
 Calcium     0.280(ppm)   
Earthworms have long been utilized as a form of nutrition. Scientists found 
that earthworms contain 78-79 g/L free amino acids and they contain a high 
concentration of important vitamins and minerals such as iron and calcium. They 
investigated the diet of Amerindians of the Amazonas in Venezuela. They found that 
these peoples used leaf and litter-feeding invertebrates as a primary source of 
proteins, fats, and essential vitamins.  
The Maori, or indigenous Polynesian population of New Zealand as well as 
various Australian aboriginal populations have been noted to use earthworms as food 
sources. 
Influence of Environmental Factors on Survival and Growth of Earthworms
14
 
A. Temperature 
Earthworms have fairly  complex  responses  to  changes  in  temperature. 
They studied the potential of several earthworm species to grow in sewage sludge, 
and they concluded that all these species have a  range of preferred temperatures for 
growth, ranging between 15°C (59°F) and 25°C (77°F). In extreme temperature 
conditions earthworms tend to hibernate and migrate to deeper layers of the windrow 
for protection.  
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B.  Moisture Content 
There are strong relationships between the moisture content of organic wastes 
and the growth rate of earthworms. In vermicomposting systems, the optimum range 
of moisture contents for most species has been reported to be between 50% and 90%.  
C. pH 
Most epigeic earthworms are relatively tolerant to pH and can tolerate pH 
levels of 5–9, but when given a choice in the pH gradient, they move toward the more 
acid material, with a pH preference of 5.0. 
D.  Aeration 
Earthworms lack specialised respiratory organs, and oxygen and carbon 
dioxide diffuse through their body wall. Thus, earthworms are very sensitive to 
anaerobic conditions.  
E.  Ammonia and Salts 
Earthworms are very sensitive to ammonia and cannot survive in organic 
wastes containing high levels of this Cation (e.g., fresh poultry litter). They also die in 
wastes with large quantities of inorganic salts.  
Characteristic composition in earthworm 
15 
 
 
 Earthworms usually contain some characteristic compositions of 
lumbrofebrine, terrestrolumbrlysin, lumbritin, hypoxanthine and other purines, 
pyrimidines, choline and guanidine.  
 The fat of earthworm is composed of octade acids, palmitic acids, high-chain 
unsaturated fatty acids, linear and odd carbon fatty acids, branched fatty acids, 
phosphatide.  
 The yellow chloragenous cells and organs of Lumbricus terrestris contain rich 
amounts of carbohydrates, lipids, protein, pigments and some alkaline amino 
acids. 
 The neutral fat consists mainly of laurel acid, oleate, myristic acid and decanoic 
acid. The fatty acids of glucolipids are decanoic acid and some short chain fatty 
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acids. The fatty acids of phosphatide are oleate, decanoic acid, linoleate and 
behenic acids.  
 A P-peptide substance exists in the gut wall of Lumbricus terrestris. Some 
active enzymes occur in the yellow chloragenous cells and organs of Lumbricus 
terrestris in high concentrations, including catalase, peroxidase, dismutase, β-
D-glucosyl enzyme, alkaline phosphatase, esterase, S-amino-γ-ketoglutaric 
dehydrogenase and porphyrin synthetase.  
 Scientists from Japan, China and Korea found and separated enzymes from the 
earthworm gut and body fluids, which can dissolve fibrin. These enzymes have 
been developed as innovative medicines to treat cerebral thrombosis and 
myocardial infarction. 
LUMBROKINASE, an active component 
Lumbrokinase, an organic compound derived from earthworms has been 
shown to offer a wide range of health benefits. Lumbrokinase is now used as a dietary 
supplement. The Lumbrokinase possesses both anti-thrombolytic and Anti-platelet 
activity. 
Lumbrokinase (LK) is a group of six novel proteolytic enzymes derived from 
the earthworm Lumbricus rubellas. The enzymes: 
• Have potent fibrin-dissolving properties  
• Decrease fibrinogen  
• Lower blood viscosity  
• And markedly reduce platelet aggregation. 
 Recent research suggests that LK may be effective in the treatment and 
prevention of ischemic heart disease, as well as myocardial infarction, 
thrombosis of the central vein of the retina, embolism of peripheral veins, and 
pulmonary embolisms. 
 One remarkable property of lumbrokinase is that, unlike the medications 
streptokinase and urokinase, it is only active in the presence of fibrin. Though 
it dissolves fibrinogen and fibrin very specifically, it hardly hydrolyzes other 
important blood proteins such as plasminogen or albumin. It has the profound 
advantage of not causing hemorrhage due to excessive fibrinolysis.  
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  Toxicological experiments have found no negative effects of Lumbrokinase 
on nervous, cardiovascular, respiratory and blood systems of rats, rabbits and 
dogs. 
Therapeutic uses 
 An enzyme complex isolated from earthworms increases the levels of tissue 
plasminogen activator (t-PA, a protein involved in breakdown of blood clots) 
and consequently shown fibrinolytic activity – without harmful side effects. 
 In a study in 2000 the complex was found to be beneficial for ischemic (clot-
caused) stroke, without increasing the risk of excessive bleeding as other 
anticoagulants can. 
 Using spectrofluorimeter and flow cytometry, a study found that this complex 
has Anti-platelet activity, Anti-thrombotic activity and anti-apoptotic activity. 
 According to the most famous ancient Chinese materia medica, earthworms 
could treat hemiplegia, fever, and blood clots. 
 Earthworms can kill bacteria and lyse foreign cells; their body fluid contains 
leukocytes that are as varied as those of many vertebrates.  
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4.3 BOTANICAL REVIEW 
Aristolochia bracteata Retz. 
Aristolochia bracteata is a large plant genus with over 500 species, belongs to 
the family Aristolochiaceae. It is an important medicinal herb and it is an origin of 
Indian subcontinent and has become naturalized in the tropical and sub-tropical areas 
around the world.  
Common names 
Worm-killer, Indian  Birthwort, Bract eated Birthwort  
Vernacular names 
 Sanskrit  : Ajaspurisaha, Aulosa, Hukka-Bel, Kalipaad 
 Hindi    : Gandan, Aulosa, Hukka-Bel, Kalipaad, Kiramar 
 Tamil   : Aadutheenda Paalai 
 Kannada  : Sanajali-Hullu, Aadumuttada Gida, Kalaguraki 
 Telugu   : Kadapara, Gadide- Gade-Para-Aku 
 Malayalam  : Atu-Tintap-Pala 
 Marathi  : Gandhaari, Gindhaan, Keedamaari 
 Bengali  :  Kiramar 
 Gujarathi    :  Kidaamaari 
 Punjabi   :  Kitamar 
 Scientific classification 
Kingdom  : Plantae  
Phylum  : Tracheophyta  
Class  : Magnoliopsida  
Order   : Piperales  
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Family  : Aristolochiaceae  
Subfamily : Aristolochioideae  
Genus   : Aristolochia  
Species  : A. bracteolate  
Binomial name : Aristolochia bracteata  
Distribution
16 
This species is globally distributed in Tropical Africa, Arabia, Sri Lanka, 
Pakistan and India. Within India, it is found in northern and central India from 
Haryana to West Bengal and southwards to Tamil Nadu and Kerala. It is common in 
dry areas, particularly on black cotton soil, usually growing as a weed.  
Ecology 
Aristolochia bracteata grows in subsaharan regions from Mali to Somalia 
through to the Arabian peninsula and India. The plant grows at elevations of 50-740m 
above sea level and and can be found on the banks of rivers, bushland, desert 
grasslands. It grows in sandy or lava soils. 
Cultivation 
17 
Aristolochi bracteata is usually gathered from the wild.  
Description
18 
a) Macroscopic: 
 Aristolochia bracteata  is a herbaceous perennial medicinal plant with cordate 
leaves and dark purple colour tubular flowers belonging to the family 
Aristolochiaceae. The climbers reach heights of 10 to 50 centimetres.  
Leaves   
 The simple leaves are alternate and cordate, membranous, entire and 
petiolate, growing on leaf stalks.  
 There are no stipules.  
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Flowers 
 The flowers grow in the leaf axils.  
 They are inflated and globose at the base, continuing as a long perianth 
tube, ending in a tongue-shaped, brightly colored lobe. There is no 
corolla. The calyx is one to three whorled, and three to six toothed.  
 The sepals are united (gamosepalous). There are six to 40 stamens in 
one whorl. They are united with the style, forming a gynostemium.  
 The ovary is inferior and is four to six locular. These flowers have a 
specialized pollination mechanism. The plants are aromatic and their 
strong scent attracts insects. The inner part of the perianth tube is 
covered with hairs, acting as a fly-trap. These hairs then wither to 
release the fly, covered with pollen.  
Fruit 
 The fruit is dehiscent capsule with many endospermic seeds. Capsule 
2-3 cm long, 12-ribbed, glabrous. Seeds may, 5-7 mm long, flat and 
dark coloured.  
b) Microsocopic: 
Leaf- 
Petiole  
 TS almost angular in outline, with one depression on the upper and two 
depressions on the lower surface; epidermis single layered followed by 
3 or 4 rows of collenchyma; below the ridges about 4 or 5 layers of 
chlorenchyma present; vascular bundles five in number arranged in a 
shallow arc; ground tissue parenchymatous. 
Midrib  
 Midrib shows a slightly convex outline adaxially, and almost circular 
abaxially; epidermal cells single layered; the upper and lower sub-
epidermal region composed of 2 to 4 layers of collenchyma; a single 
vascular strand present; ground tissue is made up of parenchyma cells; 
unicellular epidermal hairs present on abaxial epidermis. 
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Lamina  
 TS shows dorsiventral structure; epidermis single layered, composed 
of rectangular cells; trichome occasional on upper surface, simple and 
unicellular; palisade single layer; spongy tissue composed of loosely 
packed circular to oval cells; vascular strands present; stomata 
anomocytic, present on both epidermis; in surface view, adaxial 
epidermal cells straight walled, but abaxial cells rather wavy; stomatal 
number 6 to 9 /mm
2
 for adaxial epidermis and 23 to 27 / mm
2 
for 
abaxial epidermis ; stomatal index for adaxial epidermis 6 to 12 and for 
abaxial epidermis 16 to 24; palisade ratio 5 or 6; vein islet number 8 to 
12. 
Powder  
 Greyish green, shows the presence of palisade cells, fragments of 
epidermis with straight or slightly wavy walls and anomocytic stomata, 
parenchyma and collenchyma cells seen, vessels with helical, mostly 
scalariform and occasionally pitted thickenings on walls observed. 
 
Agronomic characters
19 
 It can be propagated by seeds which germinate in about two weeks. Seeds can 
be collected by bagging the fruits. The seeds are sown in June in well mannered beds. 
Seedlings are transplanted after six weeks and trained on to bamboo platforms. The 
vines flower in September and fruit during February - March. They are allowed to 
grow for two years to yield roots of marketable size. The yield of roots is estimated at 
4500-5600 kg/ha from two year old vines. The roots are collected in the autumn. The 
adhering earth is removed by minimum washing. The roots are dried in the sun or by 
gentle heat.  
Plant part used  
 Whole plant, Leaves, Seeds, Roots.  
IDENTITY, PURITY AND STRENGTH – 
Foreign matter   - Not more than 2 per cent 
Total ash    - Not more than 10 per cent 
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Acid-insoluble ash   - Not more than 1.3 per cent 
Alcohol-soluble extractive  - Not less than 12.8 per cent 
Water-soluble extractive - Not less than 25.5 per cent 
Fixed oil    - Not less than 5.3 per cent 
 
Phytochemical constituents 
 Methanolic extract of plant parts of A. bracteata was the source of 
physiological active compounds.  
 The secondary metabolites from Aristolochia species cover 16 major 
groups classified by their chemical structures, including aristolochic 
acids and esters, aristolactams, aporphines, protoberberines, 
isoquinolines, benzylisoquinolines, amides, lignans, biphenyl ethers, 
coumarins, tetralones, terpenoids, benzenoids, magnoflorine; N-
acetylnornuciferine; aristolactam; β-sitosterol and ceryl alcohol. 
 The Phytochemical analysis of this plant has revealed the presence of 
alkaloids, triterpenoids, steroids, sterols, flavonoids, tannins, phenolic 
compounds and cardiac glycosides. 
 Considerable amounts of reducing sugars in free form are present in 
the roots. The chief active principle of the drug is aristolochic acid, 
though aristolic and p-coumaric acids also appear to contribute to the 
activities of the drug.  
 Aristolochic acid is 8-methoxy-3; 4-methylenedioxy – 10 – 
nitrophenanthrene – 1 –carboxylic acid. It is intensely bitter and is 
optically inactive.  
Properties and medicinal uses 
20 
 Decoction of the whole plant is given in fever, worms infestations, skin 
disease and snake bite. 
 The plant is used in traditional medicine as a gastric stimulant and in the 
treatment of cancer, lung inflammation, dysentery and snake bites, 
antimicrobial activity, anti-arthritic activity, anti-allergic activity and anti-
oxidant property. 
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 The ethyl acetate, acetone and methanol extraction of roots showed promising 
antibacterial activity in Gram positive and Gram negative bacterial dish. 
Among them ethyl acetate extract was found to be the most effective. 
 The freshly bruised leaves are mixed with castor-oil and used in Nigeria 
topically on pimples. 
 Roots mixed with lime juice are taken for snake bite and scorpion stings in 
Nigeria. In East of Lake Chad the root is also applied topically to scorpion 
stings.  
 The flowers are sometimes worn in Northern Nigeria as charm against snake-
bite and scorpion-stings.  
 The use of the plant as antibiotics, antimalarial and aphrodisiac has been 
reported by traditional healers of Southwestern Nigeria. 
 The stem and the root contain the alkaloid aristolochic acid.  
 The dried, powdered root has been shown to increase the contractions of the 
uterus during labour. It has been used as a substitute for ergot.  
 The leaves and roots are used to get rid the body of Guinea worm (a parasitic 
infection caused by a nematode)  
Indications  
Whole plant :Dermatitis, allergic disorder, leprosy, jaundice, Worms, fever, 
Mosquito    repellent , Anodyne, purgative, emmenagogue  
Leaves :Anti-inflammatory dermatitis, rashes, skin disease, for scorpion sting, 
Antipyretic, snake bite, Antiulcer, amenorrhoea, antihelmintic, 
Antiplasmodial. 
Seeds : Antibacterial, anti-inflammatory and analgesics 
Roots : Syphilis, gonorrhoea & skin diseases, eczema  
Benefits of Worm-killer 
 In the Indigenous system of medicine, the plant was used as purgative, 
antipyretic & anti-inflammatory agents.  
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 The root part has antifungal and antibacterial activity and was used to treat 
syphilis, gonorrhoea, and skin diseases and also used during labours to 
increase uterine contraction.  
 Its leaves are bitter and anti-helmintic, antiulcer, anti-plasmodial and are 
medicinally important.  
 The whole plant is very bitter and has abortifacient, alterative, 
anthelmintic, antiperiodic, emmenagogue and purgative properties. 
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4.4 PHARMACEUTICAL REVIEW 
Pharmaceutics is a discipline of pharmacy that deals with the process of 
turning a new chemical entity to be used safely and effectively by the patients. 
(Formulation of pure drug substance into dosage form) 
  Siddha pharmaceutics has very minute chemical processes in it. It has several 
chemical processes like purification of raw substances, grinding them with herbal 
juices for several days and subjecting the ground material to fire by way of pudam 
process. Medicines prepared according to the above methods undergo several 
chemical changes.
21 
Siddha medicines are classified into internal medicines (32) and external 
medicines (32). The drug taken for dissertation is in the form of parpam. Other names 
of parpam are neeru or venneeru. Parpam comes under the category of internal 
medicines.  
Purification of the drugs included 
Purification of the drugs is mainly done to remove the toxicities, impurities 
like soil, dust, clay present in the drugs. Also the drugs when subjected to heat like 
roasting or soaked in liquids undergo certain chemical reactions such as oxidation of 
toxic substances to non-toxic, reduction of some poisonous chemicals to non-
poisonous ones, or undergo enzymatic reactions. In these ways, not only the toxicities 
and impurities are removed but also enhances the potency of the drugs. 
Poonagam 
Poonagam was soaked in buttermilk. When it repels the sand, it was taken out 
and dried, then it was grounded.   
Leaves of Aduthinna paalai 
 Aduthinna paalai was washed in the running tap water to remove the soil and 
impurities.  
 The mature leaves, insect infested leaves are removed. 
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PARPAM 
Concept and terminology 
Parpam is also known as ‗Neeru‘ . The materials that go into the preparation 
of ‗parpam‘ should first be cleaned and taken through the specified processes of 
purification that are recommended for each component. Then they are ground with 
juices of leaves, distillates or extractives and then subjected to frying or calcinations 
or suitably heating in the manner recommended in the recipe till the product is 
satisfactorily calcined. 
Method of preparation 
 The purified drugs are crushed and converted into fine powder so that they are 
ground in the mortar. These powders are put into the mortar, specified juice are added 
and ground and the mass is made into small discs and dried in sun.  
If the discs are not well dried, the ‗parpam‘ or the calx will not attain the 
specified colour, specific for the particular parpam. So, they are thoroughly dried and 
spread in a shallow earthen pan and covered with an identified pan inverted over it 
and the edges are sealed with clay smeared cloth ribbon.  
This set up is dried and then placed and burnt in kilns of suitably pre-
determined size. The calcination capsules and the contents therein should be taken 
only when the kiln has cooled down by itself.  
General precautions 
 When the discs are arranged in the pans, they should not be heaped up and 
should not be arranged in more than one layer. Only then the heat will react on the 
material properly. The pans should also be not dis-proportionately big when compared 
to the quantify of drugs and they should not be very deep. As the colour, effect and 
fineness of the ‗parpam‘ will be enhanced according to the degree of grinding; they 
should be ground very finely. 
The kiln is constructed by making circular excavations of suitable dimensions 
in places with optimum aeration and the sides are lined with bricks kilns should not be 
constructed in places where strong winds blow.  
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Usually cow dung cakes are used as fuel in kilns. However, in some specified 
instances some barks or goat dung and other materials are recommended. In cow dung 
cakes, there will be an appreciable admixture of sand or mud. Depending upon the 
degree to which there is such admixture, the number or weight of cow dung cakes 
may be increase. With adequate practical experience one can determine this correctly. 
 Half the number of cow dung cakes is spread at the bottom of the kiln and the 
calcination capsules are placed over this at the center. The remaining cow dung cakes 
are arranged over these and are ignited all around. 
 Materials like sulfur and yellow orpiment which do not withstand and strong 
heating are hidden in specified ashes when being calcined. In such cases, the ash is 
spread in the pan, the discs placed over then covered with more ash after which the 
other pan is inverted over and sealed along the seam. The product obtained by 
appropriate calcinations should be very finely ground in a mortar and taken. 
Properties 
 In general, Parpam are always white, but Thanga parpam (calx of gold) is 
light yellow in colour. They are fine in particle size and light in weight.  
     
“ePwpUe;j gbfnsy;yhk; epwkJ ntSg;Ng ahFk; 
Ntwpe;j ntSg;ig ahy;yhy; NtWepwk; gw;gkd;W 
$wpe;j jq;fk; Fyk;ngha;ah epwK kQ;rs; 
Thwpe;jg; gbNa ay;yhky; kw;nwy;yh kUl;Lj; jhNk” 
 (mfj;jpah; itj;jpa fhz;lk; -600) 
                                  
  gw;g kfpik 
tPuj;J kpf;fit gw;gq;fNs- gup 
 fhuj;J kpf;fit gw;gq;fNs 
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ghUf;Fs; khdplh; Neha;Nghf – tU 
 gz;bjUf;nfy;yh khNkfk; 
tPuflhhp – gpzpf;nfhU  
 ghuFNlhhp- tpirngW 
jPujlhup- tpidAL 
 #hpf;FO Nenuhj;jJ 
NkUf;fpiz ghug;Gwk; 
 (Njiuah; jU- Fzg;ghlk; jhJ [Pt tFg;G) 
Storage 
 They should be kept in dry, air tight container. When properly stored, they 
retain their potency for 100 years. 
Adjuvant  
 It is advised to take along with butter, ghee, honey or  milk. 
Dosage and Duration  
 Dosage is indicated according to the age of the patient. Duration is fixed, 
according to the disease condition as 3 days to 48 days. 
     Shelf life of the drugs 
The shelf life of the drugs depends on the effectiveness of the preparation. The 
efficacy, smell, taste and appearance of the drugs gradually change as time goes on 
resulting in reduced potency thereby the desired effect is not attained. But some drugs 
appear to be good externally inspite of reduced efficacy. So they should not be 
considered for consumption and should be discarded. The shelf life of parpam is 100 
years. Also the following are the analytical parameters of specifications of parpam,
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Testing parameters for Parpam -AYUSH guidelines
22
  
S.NO TESTS 
  1 Description, Colour, Odour 
  2 Identification –chemical 
  3 Particle size mesh size — 200 – 300 
  4 Loss on drying at 105 °C 
  5 Total – ash  
  6 Acid – insoluble ash  
  7 Water soluble ash  
  8 Assay of element (s)  
  9 Siddha specifications  
  10 Lusterless  
  11 Fine enough to enter the crevices of finger   
  12 Floats on water  
  13 Smokeless  
  14 Tasteless  
  15 Irreversible 
 
Traditional Tests for Parpam 
 The final product should not have the glitter or shine. 
 If a small quantity is pinched and rubbed between the thumb and fore–finger 
the particles should be so fine as to enter and reside in the furrows and 
depressions. 
 If a pinch of parpam is gently put on the surface of water in a container, the 
material should not sink, but it should float.  
 If the parpam is put into a crucible and heated in a blower or oven, it should 
not revert to its metallic state. 
4.5 SCIENTIFIC REVIEW  
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TOXICITY STUDY 
Poonagam (Earthworm)
23 
Jaganathan Anitha et.al, studied the Oral acute toxicity study of earthworm 
powder in wistar male rats that showed no toxicity even at the doses of 100, 200 and 
300 mg/kg. There was no significant mortality and changes in body weight noticed at 
all the doses tested. 
Poonaga parpam
24 
Acute oral toxicity study of Poonaga parpam (OECD -423): 
In acute oral toxicity study, there were no abnormal signs developed in wistar 
albino rats up to the dosage levels of 2000mg/ kg/ b.wt throughout the study period. 
No mortality was observed in the study period. 
28 Days repeated dose oral toxicity study of Poonaga parpam (OECD- 407)  
 Toxicity signs were not observed during the dosing period of 28 days 
 All animals from control and all the treated dose groups survived throughout 
the dosing   period of 28 days. 
 The result of haematological and biochemical investigation shows  no 
significant changes except the values of triglycerides were gradually decreased 
in all treated groups when compared to control group which was statistically 
not significant. 
 The histopathological study of various organs were normal in control, low 
dose, mid dose and high dose group. 
PHARMACOLOGICAL STUDY 
Broncho Dilator Activity 
 Poonagam (Earthworm)25,26 
 An effective asthma-calming component from earthworms was separated early 
in the 1930‘s. This component was used in experiments with rabbit lungs and reported 
that the component made bronchiectasis. Hence it could be used to resist asthma 
caused by histamine and pilocarpine. This component was injected Intravenousously 
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to the body cavity of experimental animals, 50% of the animals could withstand the 
lethal dose of histamine. 
 Aduthinna paalai (Aristolochia bracteata)27 
 H r Chitme et al., studied the Antiallergic activity of  Aristolochia bracteolata 
Lank in animal model. It was  evaluated using  compound 48/80 induced anaphylaxis, 
dermatitis, rhinitis and pruritis, as a preclinical model for acute phase of 
hypersensitivity reactions. The present study implied that the chloroform extract of 
Aristolochia bracteata had potent and significant effect in toluidine diisocyanate 
induced rhinitis in swiss albino mice. Mast cell membrane stabilization activity was 
also observed in compound 48/80 induced mast cell activation. A significant 
reduction was observed in serum nitrate levels, rat peritoneal fluid nitrate levels and 
BAL nitrate levels. The extract was also found to possess significant inhibitory effect 
on blood histamine levels. 
Anti-Inflammatory Activity    
 Poonagam (Earthworm)28 
 M.Balamurugan et al., studied the anti inflammatory activity of earthworm 
extract by using the carrageeenan induced left hind paw edema method. The results 
revealed that the histamine induced acute phase rat hind paw oedema volume and 
turpentine induced chronic phase granuloma pouch weight and its exudate volume 
was reduced significantly due to the administration of standard drug indomethacin. 
But administration of earthworm extract was found to exhibit better results in a dose 
dependent manner. Administration of 200 mg/ kg earthworm extract was found to 
reduce the above parameters and brought to near normalcy and this results was found 
to be followed by administration of 50 and 100 mg /kg, respectively. 
 Di Long ―earth dragon‖ extract in traditional Chinese medicine (TCM) is 
made from red earthworms (Lumbricus rubellus). This TCM preparation is used 
empirically to treat high fever with convulsion and inflammatory joint pain. The 
ethanolic extract of L. rubellus powder contains notable amounts of phenolic acid and 
shows an antioxidant effect in vitro. L. rubellus powder can be potentially used as a 
natural antioxidant source to treat disorders associated with inflammation and 
oxidative stress.
29 
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 Aduthinna paalai (Aristolochia bracteata) 30 
The ethanolic extract of the shade dried leaves of A. bracteata was evaluated for 
its anti inflammatory activity in wistar rats by using the carrageeenan induced left 
hind paw edema method. Significant reduction of edema volume was observed in the 
drug treated group when compared with the standard and untreated control. 
Antioxidant investigation of the ethanol extract along with its two successive fractions 
using nitric oxide and 1,1-diphenyl-2 picryl hydrazyl (DPPH)-induced free radical 
assay methods showed good free radical scavenging activity, thereby supporting its 
anti inflammatory properties. 
Anti Pyretic Activity 
 Poonagam (Earthworm)28 
 M.Balamurugan et al., studied the anti pyretic activity of earthworm extract by 
using the Brewer‘s yeast induced pyrexia in rats. The subcutaneous injection of yeast 
suspension markedly elevated the rectal temperature after 24h of administration to 
rats. Treatments with earthworm extracts at the doses of 50, 100, and 200 mg/ kg 
decreased the rectal temperature in a dose dependent manner. The anti pyretic effect 
started from the first hour and was maintained for 4h, after administration of 
earthworm extract. The result obtained from both paracetamol and earthworm extract 
treated rats were compared with the control group and a significant reduction in the 
yeast induced elevated rectal temperature was observed.  
 Aduthinna paalai (Aristolochia bracteata)31  
Pet. ether and acetone extracts of A. bracteata was investigated for their anti 
pyretic activity . Pet. ether and acetone extracts of the plant A. bracteata were 
prepared using Soxhlet extraction. Pyrexia produced in rats by injecting 20ml/kg (s.c) 
of 20% aqueous suspension of Brewer‘s yeast suspension. Extracts at 250 mg/kg 
exhibited significant anti pyretic activity. Aspirin (300mg/kg) was used as standard 
for which Pet. Ether extracts was found to be more effective than acetone extract. 
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5. STANDARDIZATION OF THE DRUG
32
  
5.1 STANDARDIZATION OF THE DRUG POONAGA PARPAM AS PER 
SIDDHA CLASSICAL LITERATURE
22
: 
 Analysis as per classical Siddha literature: 
 Floating on Water 
 Fine enough to enter the crevices of finger  
 Irreversible reaction 
 Tasteless  
 Lusterless  
1. Floating on Water: 
 A pinch of Parpam gently placed on the still surface of water in a vessel, did 
not sink immediately. It was found that the Poonaga Parpam particles floated over 
the surface of water indicated lightness of the trial. 
2. Fine enough to enter the crevices of finger : 
Parpam in well prepared form should be fine. When taken between thumb and 
index finger, the fine powder will fill up the lines of the finger print. A pinch of 
Poonaga Parpam  was taken in between the thumb and index finger and rubbed. It 
was found that the Poonaga Parpam  entered  into the lines of the finger, and was not 
easily washed out from the lines, confirmed its fineness. 
3. Irreversible reaction: 
  The well prepared Parpam does not reversible to its metallic state when heated 
with a mixture of cane jaggery, hemp powder, ghee and honey. A pinch of Poonaga 
Parpam was taken and mixed with cane jaggery, ghee and honey. It was observed that 
the Poonaga Parpam did not reversible to its metallic state.   
4. Tasteless:  
The well prepared  Parpam  should be completely tasteless .Presence of any 
taste like sweet or bitter indicate incomplete preparation which needed another 
Calcination process. When a small amount of Poonaga Parpam was kept on the tip of 
the tongue, no specific taste was found. 
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5. Lusterless: 
If any shining particles present in Parpam, it indicates that the Parpam is not 
manufactured properly and contains unchanged substances like minerals, metals and 
other toxic substances. There should be no shining particles present in the well 
manufactured Parpam. The Poonaga Parpam was taken in a Petri bowl and observed 
for any luster in daylight through magnifying glass. No luster was observed in the 
Poonaga Parpam   
The results were tabulated in Table.No.1  
     
     Finger print test 
     
                   Floating on water test  
Fig.No.6. Standardization of Poonaga parpam as per Siddha literature 
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5.2. STANDARDIZATION OF THE DRUG POONAGA PARPAM BY USING 
MODERN TECHNIQUES: 
Standardization of drugs helps to prove its identity and determination of its 
quality and potency. Standardization of the siddha formulation is based on the 
qualitative and quantitative analysis through physico‐chemical investigations and 
instrumental analysis.  
As per AYUSH protocol for standardization, the following parameters were evaluated 
 
 Organoleptic characters 
 Colour 
 Odour 
 Taste 
 State of matter  
 Consistency 
 Shape 
 Size 
 Physicochemical analysis 
 Determination of Ash Values 
 Determination of Extractive Value 
 Physical characterization 
 Chemical analysis 
 Preliminary Basic and Acidic radical studies  
 Instrumental Analysis 
 Fourier Transform Infra-Red Spectroscopy (FTIR)  
 Inductively Coupled Plasma Optical Emission Spectroscopy (ICPOES) 
 Scanning Electron Microscope with Energy Dispersive X-Ray 
Analysis (SEM with EDAX) 
 X-Ray Diffractometer (XRD) 
 Thermo Gravimetric Analysis or Thermal Gravimetric Analysis (TGA) 
The physico-chemical analysis of the test drug “Poonaga Parpam” have been 
done at The Tamil Nadu Dr.M.G.R. Medical University.  
STANDARDIZATION OF “POONAGA PARPAM” 
 
STANDARDIZATION AND PHARMACOLOGICAL SCREENING OF “POONAGA PARPAM “ Page 40 
 
Identification of organic, polymeric and inorganic functional groups was 
engaged by using modern analytical technique Fourier Transform Infra-Red 
Spectroscopy (FTIR). The particle size (Detailed high resolution images), 
Identification and quantitative analysis of chemical elements of Poonaga Parpam 
were assessed by Scanning Electron Microscope with Energy Dispersive X-Ray 
Analysis (SEM with EDAX).  
Detection of trace metals was carried out by using an analytical technique 
Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES) and 
Characterization and Identification of crystalline materials by X-Ray Diffractometer 
(XRD). The thermal analysis of the sample measured over time as the temperature 
changes by Thermo Gravimetric analysis or Thermal Gravimetric analysis (TGA). 
The above mentioned elemental analysis have been done at IIT Madras, SAIF. (FTIR, 
ICPOES, XRD, TGA) and Madurai Kamaraj University (SEM with EDAX)  
5.2.1 ORGANOLEPTIC CHARACTER 
Colour 
The Poonaga Parpam was taken into watch glasses and placed against white 
back ground in white tube light. It was observed for its colour by naked eye. 
Odour 
The Poonaga Parpam was smelled individually. The time interval among two 
smelling was kept 2 minutes to nullify the effect of previous smelling. 
Taste 
Small amount of Poonaga Parpam was kept over the tip of the tongue 
 
The results were tabulated in Table.No.2 
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5.2.2 PHYSICO CHEMICAL ANALYSIS 
33 
Physicochemical Properties of Poonaga Parpam was analyzed at The Tamil 
Nadu Dr. MGR Medical University, Anna Salai, Guindy, Chennai-600032.  
Physico-chemical studies of the test drug is necessary for standardization, as it 
helps in under-standing the significance of physical and chemical properties of the 
substance being analyzed in terms of their observed activities and especially for the 
determination of their purity and quality. The analysis includes the determination of 
ash value, Loss on drying of the sample at 105ºC, pH value and Extractive value. 
These were carried out as per guidelines. 
1. Loss on drying of the sample at 105ºC 
4g of Poonaga Parpam was weighed in a previously weighed 100ml beaker 
and heated in an oven at 105ºC for 5hours. Cooled in a dessicator and weighed. 
Repeated the procedure till constant weight was obtained. The percentage loss in 
weight of the test drug was calculated by the following formula. 
 
Calculation: 
     Loss in weight of the sample 
Percentage of Loss on Drying at 105°C =        ___________________________ x 100  
                Weight of the test drug taken 
2.Ash content 
2.a. Total ash content 
4g of Poonaga Parpam was weighed accurately in a previously ignited and 
tared silica dish. The material was evenly spread and ignited in a muffle furnace at 
600°C until it became white indicating the absence of carbon. The dish was cooled in 
a dessicator and weighed. As carbon free ash cannot be obtained in this manner, the 
dish was cooled and the residue moistened with sufficient quantity of water. Dried on 
a water bath and then ignited in the electric furnace to get the constant weight. Cooled 
the dish in a dessicator and then weighed. The percentage of total ash of air-dried 
materials was calculated as per the formula given below. 
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Calculation: 
                      Weight of the ash 
Percentage of total ash       =  ---------------------------------------    x 100 
    Weight of test drug taken 
2.b. Acid-insoluble ash 
The total ash of Poonaga Parpam was found out as described above. To the 
dish containing the total ash was added 45 ml of 1: 5 hydrochloric acid in three 
portions of 13 ml each time. Boiled gently for 5 minutes and filtered. Collected the 
insoluble matter on an ashless filter paper (Whatman No.41) and washed with 
distilled water until the residue was free from acid. Transfer the filter paper containing 
the insoluble mater to the original dish. Dried and ignited to the constant weight. 
Cooled the dish in a dessicator, and then weighed. Calculation was made by given 
formula. 
Calculation: 
  
                   Weight of the acid-insoluble residue  
Percentage of acid-insoluble ash =    ------------------------------------------- x 100 
    Weight of test drug taken  
2.c. Water Soluble Ash 
The above obtained ash was boiled for 5minutes with 25mL water. The 
insoluble ash was collected using filter paper and washed with hot water and 
transferred to the silica crucible then ignites for 15 minutes at temperature not 
exceeding 450°C. The silica crucible and residue were weighed until constant weight 
was attained for determination of weight of insoluble ash. The weight of the water 
soluble ash was determined by subtracting the weight of insoluble ash from the 
weight of total ash. 
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3. Extractive value of the test drug 
4 g of Poonaga Parpam was weighed accurately in a glass stoppered flask. 
Added 100 ml of distilled water and shaken occasionally for 6 hours and then allowed 
to stand for 18 hours. Filtered rapidly taking care not to lose any solvent and pipetted 
out 25 ml of the filtrate in a pre weighed 100 ml beaker and evaporated to dryness on 
a water bath .Kept in an air oven at 105ºC for 6 hours. Cooled in a desiccator and 
weighed. Repeated the experiment twice, and taken the average value. The percentage 
of water soluble extractive was calculated by the formula given below. 
Calculation: 
 
Weight of the extract      100 
Percentage of water soluble extract = ---------------------------------- x ------- x 100 
Weight of sample taken      25 
 
3. a. Water-soluble extractive of the test drug 
3g of Poonaga Parpam  in a glass stoppered flask and add 100 mL of distilled 
water, shake occasionally for 6 h and then allow standing for 18 h, then filter rapidly 
taking care not to lose any solvent and pipette out 25 mL of the filtrate in a pre 
weighed 100 mL beaker and evaporate to dryness on a water bath. Keep it in an air 
oven at 105°C for 6 h, cool in a desiccator and weighed. Repeat the experiment twice 
and take the average value 
 
Weight of the extract            100 
Percentage of water soluble extractive = ---------------------------------   x --------- x 100 
Weight of the sample taken   25 
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3. b. Alcohol-soluble extractive of the sample 
4 g of Poonaga Parpam was weighed accurately in a glass stoppered flask. 
Added 100 ml of distilled alcohol (approximately 95%) and shaken occasionally for 6 
hours and then allowed to stand for 18 hours. Filtered rapidly taking care not to lose 
any solvent and pipetted out 25 ml of the filtrate in a pre weighed 100 ml beaker and 
evaporated to dryness on a water bath. 
Kept in an air oven at 105ºC for 6 hours and cooled in a desiccator and 
weighed. Repeated the experiment twice, and taken the average value. The percentage 
of alcohol soluble extractive was calculated by the formula given below. 
Calculation: 
 
    Weight of the extract   100 
Percentage of alcohol soluble extract =   ------------------------------x -------- x 100 
Weight of the sample taken    25 
 
4. Determination of pH: 
5 g of Poonaga Parpam  was weighed accurately and placed in clear 100 ml 
beaker. Then 50 ml of distilled water was added to it and dissolved well. After 30 
minutes it was then applied in to pH meter at standard buffer solution of 4.0, 7.0, and 
9.2. Repeated the test four times and average was recorded. 
5. Solubility test: 
A. A little amount of the sample was taken in a clean, dry test tube and then shaken 
well with distilled water. 
B. A little amount of the sample was taken in a clean, dry test tube and then shaken 
well with con. Hcl and Con. H2SO4. Sparingly soluble character of the sample 
indicates the presence of Silicate. 
The results were tabulated in Table.No.3 
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5.2.3 CHEMICAL ANALYSIS OF POONAGA PARPAM
34
  
The chemical analysis of Poonaga Parpam was carried out in Bio chemistry 
lab, National Institute of Siddha. 
 
S.no 
EXPERIMENT OBSERVATION INFERENCE 
1.  Physical Appearance of extract Dark brown in 
colour 
 
2. Test for Silicate 
     A 500mg of the sample was 
shaken well with distilled water. 
Sparingly soluble 
Presence of 
Silicate 
3. Action of Heat 
   A 500mg of the sample was taken 
in a dry test tube and heated gently 
at first and then strong. 
 
No White fumes 
evolved. 
 
Absence of 
Carbonate 
 
 
 
4. Flame Test 
  A 500mg of the sample was made 
into a paste with Con. HCl in a 
watch glass and introduced into 
non-luminous part of the Bunsen 
flame. 
Bluish green flame 
 
Presence of 
Copper 
 
 
5. Ash Test 
A filter paper was soaked into a 
mixture of extract and dil. cobalt 
nitrate solution and introduced into 
the Bunsen flame and ignited. 
 
No Appearance of 
yellow colour flame 
 
 
 
 
 
flame 
 
 
 
flame 
Absence of 
Sodium 
 
 
 
ESTIMATION OF ACID AND BASIC RADICALS 
Preparation of Extract: 
5gm of sample was taken in a 250ml clean beaker and added with 50ml of 
distilled water. Then it was boiled well for about 10 minutes. Then it was cooled and 
filtered in a 100ml volumetric flask and made up to 100ml with distilled water. This 
preparation was used for the qualitative analysis of acidic/basic radicals and 
biochemical constituents in it. 
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S.No EXPERIMENT OBSERVATION INFERENCE 
 I. Test For Acid Radicals   
1. Test For Sulphate 
2ml of the above prepared solution 
was taken in a test tube to this 
added 2ml of 4% dil ammonium  
oxalate solution 
Cloudy appearance 
present 
 
Presence of 
Sulphate 
 
 
2. Test For Chloride 
2ml of the above prepared solution 
was added with 2ml of dil-HCl 
until the effervescence ceases off. 
No Cloudy appearance 
was formed 
 
Absence of Chloride 
3. Test For Phosphate 
2ml of the solution was  treated 
with 2ml of dil.ammonium 
molybdate solution and 2ml of 
Con.HNo3 
 No Cloudy 
appearance was 
evolved. 
Absence of  
Phosphate 
4. Test For Carbonate 
2ml of the solution was treated 
with 2ml dil. magnesium sulphate 
solution. 
Cloudy appearance 
was evolved. 
 
Presence of 
Carbonate 
5. Test For Nitrate 
1gm of the solution was heated 
with copper turning and 
concentrated H2SO4 and viewed 
the test tube vertically down. 
No Brown gas was 
evolved 
 
Absence of Nitrate 
6. Test For Sulphide 
1gm of the solution was treated 
with 2ml of Con. HCL 
No rotten egg smelling 
gas was evolved 
Absence of Sulphide 
7. Test For Fluoride & Oxalate 
2ml of solution was added with 
2ml of dil. Acetic acid and 2ml dil. 
calcium chloride solution and 
heated. 
No cloudy appearance. 
 
Absence of Fluoride 
and Oxalate 
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8. 
 
Test For Nitrite 
3drops of the solution was placed 
on a filter paper, on that-2 drops of 
dil.acetic acid and 2 drops of dil.  
Benzidine solution were placed. 
No characteristic 
changes were noted. 
Absence of Nitrite 
9. 
 
 
 
Test For Borate 
2 Pinches (50mg) of the solution 
was made into paste by using 
dil.sulphuric acid and alcohol 
(95%) and introduced into the blue 
flame. 
No Appearance of 
bluish green colour. 
Absence of Borate 
II. Test For Basic Radicals 
1. Test For Lead 
2ml of the solution was added with 
2ml of dil. potassium iodine 
solution. 
No Yellow precipitate 
was obtained 
 
Absence of Lead 
2. Test For Copper 
One pinch (25mg) of solution was 
made into paste with Con. HCl in a 
watch glass and introduced into the 
non-luminuous part of the flame. 
 
No blue colour 
appeared 
 
Absence of Copper 
 
3. Test For Aluminium 
To the 2ml of solution dil. sodium 
hydroxide was added in 5 drops to 
excess. 
No yellow Colour  
appeared 
 
 
 
 
 
 
 
 
 
characteristic changes 
chara 
Absence of    
Aluminium. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. Test For Iron 
a. To the 2ml of solution, added 
2ml of dil. ammonium solution 
b. To the 2ml of extract 2ml  
thiocyanate solution and 2ml  of 
con HNO3 were added 
Mild  Red colour 
appeared 
 
 
Presence of Iron 
 
 
 
5. Test For Zinc 
To 2ml of the solution dil. sodium 
hydroxide solution was added in 5 
No White precipitate 
was  formed 
 
Absence of Zinc 
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drops to excess and dil. A 
mmonium chloride was added. 
6. Test For Calcium 
2ml of the solution was added with 
2ml of 4% dil.ammonium oxalate 
solution 
Cloudy appearance 
and white precipitate 
was formed 
 
Presence of calcium 
7. Test For Magnesium 
To 2ml of solution dil. sodium 
hydroxide solution was added in 5 
drops to excess. 
No  White precipitate 
was obtained 
Absence of 
Magnesium 
8. Test For Ammonium 
To 2ml of solution 1 ml of 
Nessler's reagent and excess of 
dil.sodium hydroxide solution 
were added. 
No Brown colour 
appeared 
Absence of 
Ammonium 
9. Test For Potassium 
A pinch (25mg) of solution was 
treated with 2ml of dil. sodium 
nitrite solution and then treated 
with 2ml of dil. cobalt nitrate in 
30% dil. glacial acetic acid. 
No Yellow precipitate 
was obtained 
Absence of 
Potassium 
10. Test For Sodium 
2 pinches (50mg) of the solution 
was made into paste by using HCl 
and introduced into the blue flame 
of Bunsen burner. 
No yellow colour 
flame evolved. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Absence of Sodium 
11. Test For Mercury 
2ml of the solution was treated 
with 2ml of dil. sodium hydroxide 
solution. 
No Yellow precipitate 
was obtained 
Absence of Mercury 
12. Test For Arsenic 
2ml of the solution was treated 
with 2ml of dil. sodium hydroxide 
solution. 
No  Brownish red 
precipitate was 
obtained 
Absence of Arsenic 
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III. Miscellaneous 
1. 
Test For Starch 
2ml of  solution was treated with weak 
dil.Iodine solution 
No Blue colour 
developed 
Absence of starch 
2. 
Test For Reducing Sugar 
5ml of Benedict's qualitative solution 
was taken in a test tube and allowed to 
boil for 2 minutes and added 8 to 10 
drops of the solution and again boil it 
for 2 minutes. The colour changes 
were noted. 
No Brick red colour 
is developed 
Absence of  
reducing sugar 
3. 
Test For Alkaloids 
a) 2ml of the  solution was treated 
with 2ml of dil.potassium lodide 
solution. 
b)  2ml of the  solution was treated 
with 2ml of dil.picric acid. 
c)  2ml of the  solution was treated 
with 2ml of dil.phosphotungstic acid. 
 
 
No Yellow colour 
developed 
 
 
Absence of 
of Alkaloid 
 
4 
Test For Tannic Acid 
2ml of  solution was treated with 2ml 
of dil. ferric chloride solution 
  
No Blue-black 
precipitate was 
obtained 
Absence of Tannic 
acid 
5 
Test For Unsaturated Compound 
To the 2ml of  solution , 2ml of dil. 
Potassium permanganate solution was 
added. 
Potassium 
permanganate was 
not decolourised 
Absence of 
unsaturated 
compound 
6 
Test For Amino Acid 
2 drops of the  solution was placed on 
a filter paper and dried well. 20ml of 
Burette reagent was added. 
No Violet colour 
appeared 
 
Absence of amino 
acid 
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Results were discussed in Table.No.4 
 
 
 
 
 
 
 
 
 
 
7 
Test For Type of Compound 
2ml of the  solution was treated with 2 
ml of dil. ferric chloride solution. 
No green and red 
colour developed 
 
 
No Red colour 
developed 
 
 
 
 
No Violet colour 
developed 
 
 
 
No Blue colour 
developed. 
 
 
Absence of quinole 
pinephrine and 
pyrocatecho l  
 
Absence of 
Antipyrine, 
Aliphatic amino 
acid and meconic 
acid. 
 
Apomorphine 
salicylate and 
Resorcinol were 
absent 
 
Morphine, Phenol 
cresol and 
hydrouinone were 
Absent. 
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5.2.4. FOURIER TRANSFORM INFRARED SPECTROSCOPY (FTIR)
35,36 
Instrument details:  
Model   :  Perkin Elmer- Spectrum one: FT-IR Spectroscopy  
Scan Range   :  MIR 450-4000 cm-1  
Resolution   :  4cm-1 
Principle: 
 Fourier Transform Infrared Spectroscopy (FTIR) is an analytical technique 
used to identify mainly organic materials. FTIR analysis results in absorption spectra 
which provide information about the chemical bonds and molecular structure of a 
material. The FTIR spectrum is equivalent to the "fingerprint" of the material and can 
be compared with cataloged FTIR spectra to identify the material. 
 
              
             Fourier Transform Infrared Spectroscopy (FTIR) 
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FTIR MECHANISM 
 
     
           Mechanism of FTIR analyzer 
 
Fourier Transforms Infrared Spectroscopy analytical capabilities: 
 Identifies chemical bond functional groups by the absorption of infrared 
radiation which excites vibrational modes in the bond 
 Especially capable of identifying the chemical bonds of organic materials  
 Detects and Identifies organic contaminants  
 Identifies water, phosphates, sulphates, nitrates, nitrites, and ammonium ions  
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 Detection limits vary greatly, but are sometimes <10
13
 bonds/cm
3
 or 
sometimes sub monolayer  
 Useful with solids, liquids, or gases. 
Applications: 
  Infrared spectrum is useful in identifying the functional groups like -OH, -
CN, -CO, -CH, -NH2, etc. Also quantitative estimation is possible in certain 
cases for chemicals, pharmaceuticals, petroleum products, etc. Resins from 
industries, water and rubber samples can be analyzed. 
Sample preparation method: 
 FT-IR spectra were recorded at SAIF, IIT Madras, India. The Perkin Elmer 
Spectrum One Fourier Transform Infrared (FTIR) Spectrometer was used to derive 
the FT IR Spectra of Poonaga Parpam in Potassium Bromide (KBr) matrix with scan 
rate of 5 scan per minute at the resolution 4cm-1 in the wave number region 450-
4000cm-1. The samples were grounded to fine powder using agate motor and pestle 
and then mixed with KBr. They were then Pelletized by applying pressure to prepare 
the specimen (the size of specimen about 13 mm diameter and 0.3 mm in thickness) to 
recorded the FT- IR Spectra under Standard conditions. FT- IR Spectra were used to 
determine the presence of the functional groups and bands in the Poonaga Parpam. 
The recorded spectrum shown in Fig.No.7  
 
 
 
 
 
 
 
 
STANDARDIZATION OF “POONAGA PARPAM” 
 
STANDARDIZATION AND PHARMACOLOGICAL SCREENING OF “POONAGA PARPAM “ Page 54 
 
5.2.5. ICPOES (INDUCTIVELY COUPLED PLASMA OPTIC EMISSION 
SPECTROMETRY)
37 
Instrument details:  
 Manufacturer:  Perkin Elmer 
Model:    Optima 5300 DV ICP-OES Inductively Coupled Plasma        
Spectrometer (ICP) 
Principle: 
In this technique, the high temperature plasma source atomizes the sample and 
excites the atoms resulting in emission of photons. The atoms of each element in the 
sample emit specific wavelength of light. The emission spectrum from the plasma is 
dispersed by an optical spectrometer, so that intension of the individual wavelength 
can be measured. The number of photos emitted is directly proportional to the 
concentration of the element. The photos may be detected either sequentially or 
simultaneously. Quantitative analysis is achieved by measuring the intensity of these 
specific wavelength and after performing the calibration using known standards. 
Identifying the presence of emission at the wavelength characteristic of the element of 
interest obtaining quantitative information i.e how much of an element is in sample 
can be accomplished using plots of emission intensity versus concentration called 
calibration curves. 
Application: 
The analysis of major and minor elements in solution samples. 
Objectives: 
 Determine elemental concentrations of different metals. 
 Learn principles and operation of the ICP-OES instrument 
 Develop and put on a method for the ICP-OES sample analysis 
 Enhance the instrumental conditions for the analysis of different elements 
 Probes the outer electronic structure of atoms 
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                     ICP-OES ANALYSER (Perkin Elmer Optima 5300 DV) 
 
     
   Mechanism of ICP-OES analyzer 
 
Mechanism:  
In plasma emission spectroscopy (OES), a sample solution is presented into 
the core of inductively coupled argon plasma (ICP), which generates temperature of 
approximately 8000°C. At this temperature all elements become thermally excited 
and emit light at their characteristic wavelengths. This light is collected by the 
spectrometer and passes through a diffraction grating that serves to resolve the light 
into a spectrum of its essential wavelengths. Within the spectrometer, this deflected 
light is then collected by wavelength and amplified to yield an strength of  
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measurement that can be converted to an elemental concentration by comparison with 
standardization values. 
Sample preparation – Microwave Digestion 
The Inductively coupled plasma optical emission spectrometric (ICP-OES) 
analysis was done in SAIF, IIT MADRAS, Chennai-36 using Perkin Elmer Optima 
5300 DV. 
 Weigh 0.37 g of test sample and transfer into a liner provided with instrument. 
 Slowly add 9ml of Nitric acid or Sulphuric acid such that no piece of sample 
sticks on the slide. 
 Mix thoroughly and allow reacting for few minutes. 
 Place the liner in the vessel jacket. 
 Close the screw cap hand- tight in clockwise direction. 
 Seal the vessel and placed in the rotor fixed in microwave. 
 Set temperature to 180°C for 5 minutes, hold at 180°C for least 10 minutes. 
 Allow the vessels to cool down to a vessel interior temperature below 60°C 
and to a vessel surface temperature (IR) below 50°C before removing the 
rotor. 
 The digested sample was made up to 100ml with Millipore water. 
 If visible insoluble particles exist, solution could be filtered through whatmann 
filter paper. 
 Transfer the digested solution into plastic containers and label them properly. 
 
 
 
 
 
 
 
STANDARDIZATION OF “POONAGA PARPAM” 
 
STANDARDIZATION AND PHARMACOLOGICAL SCREENING OF “POONAGA PARPAM “ Page 57 
 
5.2.6. SCANNING ELECTRON MICROSCOPY (SEM) WITH ENERGY 
DISPERSIVE X-RAY ANALYSIS (EDX)
38
 : 
Instrument details:  
Model:  The VEGA TESCAN 3 instrument is used with tungsten filament to 
image the samples. 
                                              
 
          SEM INSTRUMENT 
                                                                           
                    SEM MECHANISM 
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Principle : 
Scanning electron microscopy with energy dispersive X-ray spectroscopy 
(SEM/EDX) is the best known and most widely-used of the surface analytical 
techniques. A scanning electron microscope (SEM) is a type of electron 
microscope that produces images of a sample by scanning it with a focused beam 
of electrons. The electrons interact with atoms in the sample, producing various 
signals that can be detected and that contain information about the sample's 
surface topography and composition. The electron beam is generally scanned in 
a raster scan pattern, and the beam's position is combined with the detected signal to 
produce an image. SEM can achieve resolution better than 1 nanometer. Specimens 
can be observed in high vacuum, in low vacuum, in wet conditions (in environmental 
SEM), and at a wide range of cryogenic or elevated temperatures. 
The most common SEM mode is detection of secondary electrons emitted by 
atoms excited by the electron beam. The number of secondary electrons depends on 
the angle at which beam meets surface of specimen, i.e. on specimen topography. By 
scanning the sample and collecting the secondary electrons with a special detector, an 
image displaying the topography of the surface.  
An Energy Dispersive X-Ray Analyzer (EDX or EDA) is widely used for 
elemental identification and quantitative compositional information of the test 
substances. Scanning electron microscope provides high quality images with ~X50, 
000 magnifications allowing up to nano particles size to be seen. 
Applications:  
 Identification of metals and materials 
 Particle contamination identification and elimination 
 Classification of materials 
 Examination of surface morphology (including stereo imaging)  
 Analysis and identification of surface and airborne contamination 
 Powder morphology, particle size and analysis 
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Sample preparation method: 
All samples must be of an appropriate size to fit in the specimen chamber and 
are generally mounted rigidly on a specimen holder called a specimen stub. For 
conventional imaging in the SEM, specimens must be electrically conductive, at least 
at the surface, and electrically grounded to prevent the accumulation of electrostatic 
charge at the surface. Nonconductive specimens tend to charge when scanned by the 
electron beam, and especially in secondary electron imaging mode, this causes 
scanning faults and other image artifacts. They are therefore usually coated with an 
ultrathin coating of electrically conducting material, deposited on the sample either by 
low-vacuum sputter coating or by high-vacuum evaporation.  
Coating: 
 For best images, and to avoid charging of instances, it is desirable to gold or 
carbon coat the sample prior to examination. 
 Au coating indeed generates Au particles, whose sizes increase significantly 
with coating time. Two minutes coating may have particles in the range of 
5~20 nm. 
In the present study, A representative portion of each sample was sprinkled 
onto a double side carbon tape and mounted on aluminum stubs in order to get a high 
quality secondary electron image for SEM examination.  
The sample is coated with gold in vacuum chamber by adopting suitable 
reaction conditions. The gold coated is further used to record SEM images. The SEM 
instrument is also connected with EDX tool for analyzing the presence of atomic 
elements in the sample.   
SEM picture and EDX results of Poonaga Parpam was shown in Fig.No.7 and 8 
EDX results of Poonaga Parpam was represented in Table.No.7 
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5.2.7. X-RAY DIFFRACTOMETRY (XRD) 
39
: 
Instrument details 
Model : Bruker discover D8 X ray diffractometer.  
X- Ray Diffraction:  
 The x-ray diffraction technique is used as a basic characterization tool for 
different materials. This technique has appeared as powerful tool for determining the 
crystal structure chemical analysis, stress measurements, phase equilibria and particle 
size. The XRD pattern is the fingerprint of a crystalline material as this technique 
gives information on the phase, purity, and structure of a material. 
 
         X-RAY DIFFRACTOMETRY (XRD) 
Principle:  
X-ray powder diffraction is most widely used non-destructive technique for 
investigation of structural properties of crystalline materials. X-ray diffraction is 
based on constructive interference of monochromatic X-rays and a crystalline sample.  
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The spacing of atoms in crystal lattices is of the same order as the wavelength 
of X-radiation (0.1 to 100 Angstrom ). Von Laue discovered (1912) that a crystal 
could be used as a diffraction grating for X-rays.  
William Lawrence Bragg discovered (1912) law relating the spacing between 
atoms in a crystal to the angle at which X-rays are scattered when they strike the 
crystal. Bragg equation relates the spacing between adjacent crystal planes and the  
angle of diffraction. 
n = 2d sin  
  Where, n = integer determined by the order given, d = spacing between 
crystal planes , = angle of scattering, =wavelength of x-ray beam , = diffraction 
angle 
Applications:  
 Quantitative analysis of organic minerals, metals and alloys, crystallographic 
studies. 
Sample Preparation method:  
Poonaga parpam were characterized using a X-ray diffractormeter ( D8 
Focus, Bruker) equipped with a photo scintillation detector at IIT Madras, Saif. 
Angular range (2θ=10-60°), rate 0.01°/sec.  200mg of sample was taken. Sample was 
grinded to fine powder. Powder less than ~10 μm (or 200-mesh) in size is preferred. 
The powder was mounted on sample holder. Gently pressed the powder flush with the 
sample holder using a glass slide. Removed excess powder from the sample holder 
edges and carefully placed in the appropriate XRD slot and subjected for reading.  
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5.2.8.THERMOGRAVIOMETRIC ANALYSIS (TGA) 
40
:  
Instrument details 
Model:  STA 449 F3 Jupiter 
 
          Thermo Gravimetric Analysis (TGA) 
Principle: 
 Thermo Gravimetric Analysis (TGA) is an analytical technique used to 
determine a material’s thermal stability and its fraction of volatile components by 
monitoring the weight change that occurs as a specimen is heated. The measurement 
is normally carried out in air or in an inert atmosphere, such as helium or argon, and 
the weight is recorded as a fraction of increasing temperature. Sometimes, the 
measurement is performed in a lean oxygen atmosphere (1 to 5% O2 in N2 or He ) to 
slow down oxidation. 
 In addition to weight changes, some instruments also record the temperature 
difference between the specimen and one or more reference pans (differential thermal 
analysis, or DTA) or the heat flow into the specimen pan compared to that of the 
reference pan (Differential Scanning calorimetry or DSC). The latter can be used to 
monitor the energy released or absorbed via chemical reactions during the heating 
process. In the particular case of carbon nanotubes, the weight change in an air 
atmosphere is typically a superposition of the weight loss due to oxidation of carbon 
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into gaseous carbon dioxide and the weight gain due to oxidation of residual metal 
catalyst into solid oxides. 
Applications: 
 Current areas of applications of thermal analysis include environmental 
measurements, compositional analysis, product reliability, stability, chemical 
reactions, and dynamic properties. TGA has been used in the kinetic analysis of 
polymer stability, compositional analyses of multicomponent materials, atmospheric 
analyses and corrosion studies. 
Thermal analysis of parpam: 
 To differentiate between different polymorphic structures 
 To investigate the transformations which occur during the polymorphic 
transformation by using different heating rates 
 To determine polymorphic purity 
 Compositional analysis 
 To investigate thermal stability and the effect of addictives 
 To measure the unreacted organic species content of herbo- metallic 
preparations by heating a sample and to remove the resin by application of 
heat 
 A better understanding of the influence of temperature on the properties of 
herbo- metallic preparations 
 To optimize processing conditions and improve product quality. 
Sample preparation method: 
 Thermo Gravimetric analysis was carried out in IIT madras, SAIF. Good 
thermal contact between the sample and heat- flux sensor is an indispensable 
requirement for optimum results. 12.4 mg of the sample is evenly distributed in the 
bottom of the sample crucible. When filling the crucible, no sample material may 
remain on the edge of the crucible. The sample crucible was placed on the front- hand 
sample support and subjected for reading. 
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6.1. EVALUATION OF BRONCHODILATOR ACTIVITY OF POONAGA 
PARPAM USING HISTAMINE INDUCED BRONCHO CONSTRICTION IN 
GUINEA PIG
41,42 
Aim: 
To study the Broncho dilator activity of Poonaga parpam by histamine 
induced bronchoconstriction in Guinea pig . 
 
Materials and methods: 
Test Substance : Poonaga Parpam  
Animal Source : TANUVAS, Madhavaram, Chennai.   
Animal : Albino Guinea pig  
Body Weight               : 700 gms 
Acclimatization : 14 days prior to dosing. 
Veterinary examination :  Prior and at the end of the acclimatization period. 
Diet : Pellet feed 
Water :  Aqua guard portable water in polypropylene bottles. 
Housing & Environment :  The animal was housed in Polypropylene cage  
  provided with bedding of husk. 
Housing temperature :  25±2°C 
Air changes  : 10 to 15 per hour  
Dark and light cycle  :  12:12 hours. 
 
Selection of animals: 
           Healthy albino guinea pig weighing 700 gms of male sex was used in this 
study with the approval of the Institutional Animal Ethics Committee and obtained 
from the animal laboratory IAEC approved no: IAEC/ LI/23/CLBMCP/2017. 
           The animal was kept in plastic cage and maintained under controlled 
environment (temperature 25±2
◦
C and 12hrs dark and light cycle) with standard diet, 
water ad libitum during experiment. The animal was allowed an acclimatization 
period of 14 days before actual experiment. The animal experiment was performed 
with accordance to legislation on welfare.  
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PROCEDURE
43
  
Histamine was dissolved in distilled water to prepare 0.2% w/v solution. 
Overnight fasted Guinea pigs with free access to water were divided into four groups 
each containing 6 animals.   
 Group-I was treated as Vehicle Control- Honey (p.o)  
 Group-II received standard drug Chlorpheniramine maleate (2 mg/kg , i.p) 
 Group-III Poonaga parpam (100mg/kg, p.o) 
 Group-IV Poonaga parpam (200mg/kg, p.o) 
All the doses were given orally once a day for 5 days. Prior to drug treatment each 
animal was placed in the histamine chamber and exposed to 0.2 % histamine aerosol 
using a ultra-sound nebulizer in an aerosol chamber under constant pressure of 
40mm/Hg. The required time for appearance of pre convulsive dyspnoea produced by 
the histamine was noted for each animal. The pre convulsive time (PCT) was 
determined from the time of exposure to onset of dyspnoea leading to the appearance 
of convulsions. As soon as the PCT were noted, the animal were removed from the 
chamber and placed in fresh air for recovery. This time for pre convulsive dyspnoea 
was recorded as basal value. Guinea pigs were then allowed to recover from dyspnoea 
for 2 days. Animals in group 1 served as vehicle control and received honey. The 
animals of group 2 received the standard drug - Chlorpheniramine maleate 
intraperitoneally and group 3 &  4 were given, by oral intubation, 100 and 200mg/kg 
of the test drug Poonaga parpam, respectively. In order to observe the Broncho 
dilator effect of the test substance on induced broncho contractions, the test material  
Poonaga parpam  was added in a cumulative fashion (100 mg and 200 mg ) to obtain 
the concentration-dependent inhibitory responses. These animals were again subjected 
to histamine aerosol after 1hr of drug administration and PCT was determined.  The 
protection offered by treatment was calculated by using the formula 
Percentage Protection = (1 - T1/T2) X 100    Where,  
T1 = the mean of PCT before administration of test drugs.  
T2 = the mean of PCT after administration of test drugs 
44
.  
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6.2. EVALUATION OF ANTI-INFLAMMATORY ACTIVITY OF POONAGA 
PARPAM IN WISTAR ALBINO RATS
45 
Aim: 
  To study the Anti-inflammatory effect of Poonaga Parpam in Wistar albino 
rats by Carrageenan-induced rat paw edema. 
Materials and methods: 
Test Substance  :  Poonaga Parpam 
Animal Source  :  TANUVAS, Madhavaram, Chennai.   
Animals   :  Wistar Albino Rats (Male -12, Female -12) 
Age    :  6-8 weeks 
Body Weight    : 140-160gm. 
Acclimatization  :  14 days prior to dosing. 
Veterinary examination :  Prior and at the end of the acclimatization  
period. 
Identification of animals      :  By cage number, animal number and individual 
             marking by  using Picric acid.                                                                
Diet    :  Pellet feed 
Water    :  Aqua guard portable water in polypropylene  
bottles. 
Housing & Environment :  The animals were housed in Polypropylene  
                     cages provided with bedding of husk. 
Housing temperature :  24-28°C 
Relative humidity  : between 30% and 70%, 
Air changes    :  10 to 15 per hour  
Dark and light cycle   :  12:12 hours. 
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Selection of animals: 
Healthy Wistar albino rats (140- 160g) of both sexes were used for this study 
with the approval of the Institutional Animal Ethics Committee and obtained from the 
animal laboratory. IAEC approved no: NIS/IAEC-III/03/29092016. 
The animals kept in plastic cages and maintained at 24-28°C. All the rats were 
housed individually with free access to food, water ad libitum. They were fed with 
standard diet and kept in well ventilated animal house and they were also maintained 
with alternative dark-light cycle of 12hrs throughout the studies. Rats were allowed an 
acclimatization period of 14 days before actual experiments. The rats were closely 
observed for any infection and if they show any signs of infection they were excluded 
from the study. The animal experiment was performed with accordance to legislation 
on welfare. 
The experimental protocol
46,47 
Animal grouping: 
Both sex of Adult wistar Albino rats weighing (140-160g) were used in this 
study. Rats were divided into 4 groups, consisting six animals for each group.  
Group I : Vehicle control - received only honey orally 
Group II : Received Standard drug Indomethacin (10mg/kg orally) 
Group III : Received Poonaga Parpam (12 mg/kg orally)  
Group IV : Received Poonaga Parpam (24 mg/kg orally) 
Acute anti inflammatory effect was evaluated by carrageenan-induced hind 
paw edema. Carrageenan was administrated by sub-plantar injection of 0.1 ml freshly 
prepared 1% suspension in right hind paw in rats. Group II, III, and IV of animals 
were pretreated with 10 mg/kg body weight standard drug Indomethacin, Poonaga 
Parpam 12 mg/kg and 24 mg/kg at 1hr before eliciting paw edema. Rat’s paw volume 
was measured initially and then 1,2,3 hrs after the carrageenan injection by using 
plethysmographic method. 
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The edema inhibitory activity was calculated according to the following 
formula- 
Edema (%) inhibition = (1-D/C) 100 
Where, 
D-represents the percentage difference in increased paw volume after the 
administration of test drugs to the rats. 
C-represents the percentage difference of increased volume in the control 
groups. 
Statistical analysis 
All the results were reported as mean ±  SD. They were further analyzed using 
one way analysis of variables (ANOVA) followed by Dunnet’s multiple comparison 
test. 
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6.3 EVALUATION OF ANTI-PYRETIC ACTIVITY OF POONAGA PARPAM 
IN WISTAR ALBINO RATS
48,49 
 
Aim 
  To study the Anti-Pyretic Activity effect of Poonaga Parpam  in Wistar albino 
rats by Brewer’s yeast induced pyrexia. 
Materials and methods: 
Test Substance  :  Poonaga Parpam 
Animal Source  :  TANUVAS, Madhavaram, Chennai.   
Animals   :  Wistar Albino Rats (Male -12, Female -12) 
Age    :  6-8 weeks 
Body Weight    : 140-160gm. 
Acclimatization  :  14 days prior to dosing. 
Veterinary examination :  Prior and at the end of the acclimatization  
period. 
Identification of animals      :  By cage number, animal number and individual  
 
  marking by  using Picric acid. 
                                                                
Diet    :  Pellet feed 
Water    :  Aqua guard portable water in polypropylene  
bottles. 
Housing & Environment :  The animals were housed in Polypropylene  
                                           cages provided with bedding of husk. 
Housing temperature :  24-28°C 
Relative humidity  : between 30% and 70%, 
Air changes    :  10 to 15 per hour  
Dark and light cycle   :  12:12 hours. 
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Selection of animals: 
 Healthy Wistar albino rats (140- 160g) of both sexes were used for this study 
with the approval of the Institutional Animal Ethics Committee and obtained from the 
animal laboratory. IAEC approved no : NIS/IAEC-III/03/29092016.  
The animals kept in plastic cages and maintained at 24-28°C. All the rats were 
housed individually with free access to food, water ad libitum. They were fed with 
standard diet and kept in well ventilated animal house and they were also maintained 
with alternative dark-light cycle of 12hrs throughout the studies. Rats were allowed an 
acclimatization period of 14 days before actual experiments. The rats were closely 
observed for any infection and if they show any signs of infection they were excluded 
from the study. The animal experiment was performed with accordance to legislation 
on welfare. 
The experimental protocol
50 
Animal grouping:  
Both sex of Adult wistar Albino rats weighing (140-160g) were used in this 
study. Rats were divided into 4 groups, consisting six animals for each group. 
Group I :Control -Honey  plus yeast injection 
Group II :Received Standard drug Paracetamol (150 mg/kg orally plus 
yeast injection)  
Group III :Received Poonaga Parpam (12 mg/kg orally plus yeast 
injection)  
Group IV :Received Poonaga Parpam (24 mg/kg orally plus yeast 
injection) 
Brewer’s yeast induced hyperpyrexia method 
The animals were fasted overnight with free access to water prior to the 
experimental procedure. The normal temperature of each rat in four groups was 
measured rectally at one hour interval on a clinical thermometer.  
Before yeast injection the basal rectal temperature of rats was recorded by 
inserting the clinical thermometer to a depth of 2 cm into the rectum and after  
recording animals were given subcutaneous injection of 10ml/kg of 20% w/v yeast 
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suspended in normal saline below the nape of the neck for elevation of body 
temperature of rats.  
After 8 hours of yeast injection, rats which shows a rise in temperature of 
atleast 1 c were taken for the study. The honey was administered orally to the control 
groups of animals and paracetamol at the dose of 150mg/ml was administered orally 
to the standard groups of animals.  
Poonaga Parpam was administered orally at a dose of 12 mg/kg and 24 mg/kg 
of body weight to Group –III and Group –IV  respectively. Rectal temperature was 
recorded by clinical thermometer at 0, 1, 2, 3hrs after drug administration and 
tabulated.
51 
 
Evaluation of parameters 
Anti pyretic activity was evaluated by comparing initial rectal temperature 
(°C) before yeast injection, with rectal temperature (°C) after 8 hours of yeast 
injection at different time  intervals. 
 
Statistical analysis 
All the results were reported as mean ± SD. They were further analyzed using 
one way analysis of variables (ANOVA) followed by Dunnet’s multiple comparison 
test. 
 
RESULTS 
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7. RESULTS 
Many studies have been carried out to bring the efficacy and potency of the 
drug Poonaga parpam. The study includes literary collections, organoleptic character, 
physicochemical analysis, pharmacological and analytical studies. The drug Poonaga 
parpam has been selected from the text “Sikicha Rathina Deepam”. 
 Botanical aspect explains the active principle and medicinal uses of the plants. 
 Gunapadam review brings the effectiveness of the drug in the management of 
Bronchial asthma. 
 The pharmacological review explains about the evaluation of Broncho dilator, 
Anti inflammatory, Anti pyretic activities. 
 
5. STANDARDIZATION OF THE DRUG 
5.1 STANDARDIZATION OF THE DRUG POONAGA PARPAM AS 
PER SIDDHA CLASSICAL LITERATURE: 
Siddhars used these following standardization methods to ensure the safety 
and efficacy of the parpam. It shows the effectiveness of the drug. 
Table.No.1 Results of Siddha Standardization 
S.No. Parameter Results of  
Poonaga parpam 
Interpretation 
1.  Floating on Water Floats on water  Lightness of drug. 
 
2.  Finger Print Test Impinged in the 
furrow of fingers 
Indicates fine particles of 
powder. 
3.  Luster Lusterless Change of specific  
character of raw material 
after incineration 
4.  Taste  No specific taste, 
Mild irritation is felt 
 
Change of specific  
character of raw material 
after incineration 
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Interpretation:  
1. Floating on water:  
The test drug which floats on water has less specific gravity. Thus 
Poonaga parpam possesses specific gravity less than the water. 
2. Finger print test:  
Only the particles which are in micro fine size can enter into the furrows of 
the finger print. Finger print test indicates the presence of micro fine particles in 
Poonaga parpam. 
3. Lusterless & taste: 
Poonaga parpam is lusterless and tasteless because there is no free metal 
present. 
 
       5.2 STANDARDIZATION OF THE DRUG POONAGA PARPAM BY 
USING MODERN TECHNIQUES: 
Traditional remedies is advantageous, it does suffer some limitations. The 
main limitation is the lack of standardization of raw materials, of processing methods 
and of the final products, dosage formulation, and the non- existence of criteria for 
quality control. Standardization of the drug is more essential to derive the efficacy, 
potency of the drug by analyzing it through various studies. Following tables and 
charts are the results of physicochemical and chemical analysis. Physical 
characterization and estimation of basic and acidic radicals have been done and 
tabulated. Pharmacological activity and analytical studies of the drug were derived. 
Its results has been tabulated below. 
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5.2.1 ORGANOLEPTIC CHARACTERS: 
 
Table.No.2. Organoleptic characters of Poonaga parpam 
 
 
 
 
 
 
Table.No.3. Physicochemical characterization of Poonaga parpam 
 
S.No Parameters Percentage 
1 Loss on drying Less than 1% 
2.a Total ash value 24.72%   
2.b Acid insoluble ash 0.72%   
2.c Water soluble ash 6.94%     
3.a Water soluble extraction 1.88% 
3.b Alcohol soluble extraction 3.54% 
4 pH 8.4 
5 Solubility Soluble in acids (Hcl 
and H2So4) 
 
Interpretation 
The stability of a drug and its shelf–life are reliant on moisture content. 
Determination of moisture (Loss on drying) in a drug is one of the important tests in 
pharmaceutical analysis. The analytical parameters like total Ash value, Acid 
S.No Parameter Results 
1 Colour Dark brown coloured  
2 Odour Odourless  
3 Taste Tasteless  
4 State of matter Solid 
5 Consistency Powder 
RESULTS 
 
STANDARDIZATION AND PHARMACOLOGICAL SCREENING OF “POONAGA PARPAM ” Page 75 
 
insoluble ash value, Loss on drying values are helping us to interpret the digestion and 
solubility capacity of the drug.  
 
Physico-chemical analysis of Poonaga parpam showed that Loss on drying 
(LOD) is less than 1% which shows that low moisture content present in the prepared 
medicine. Increased moisture content is the issue for instability of a drug and lesser 
shelf life of a drug. Since Poonaga parpam was well prepared, it could get maximum 
stability and better shelf life. Longer shelf life i.e., 100 years for Parpam mentioned in 
Siddha literature is justified from the above observation. 
By the above results, the trial drug shows that total ash value was found to be 
24.72% whereas the acid insoluble ash and water soluble ash was 0.72% and 6.94%  
respectively. The value of total ash in the formulation is high because of the presence 
of inorganic ingredients and the method of preparation of this drug is calcination 
procedure. Total ash value used to estimate the inorganic material such as silicate, 
carbonates, oxalates and phosphates.   
The water soluble extractive values indicates the presence of sugar, acids. The 
alcohol soluble extractive values indicates the presence of polar constituents like 
phenols, alkaloids, steroids, glycosides, flavonoids. Water soluble extractive and 
alcohol soluble extractive values of this formulation was 1.88% and 3.54% 
respectively. 
 pH of the trial drug was 8.4. It shows the alkalinity of the drug. The adjuvant 
of the drug is honey, which possesses acidic pH (3.4- 6.1). Hence, this adjuvant 
reduces the alkalinity of Poonaga parpam. According to pharmacokinetics, alkaline 
drugs are absorbed in alkaline environment i.e., the intestine.  
The test drug is not soluble in water medium and well soluble in Hcl and 
H2So4.  
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5.2.3 CHEMICAL ANALYSIS OF POONAGA PARPAM 
S.NO          Parameter                       Result 
1 Test for silicate Present 
2 Action on heat - 
3 Flame test Bluish green flame indicates 
the presence of copper 
4 Ash test - 
 
Table.No.4. Results of basic and acidic radical studies of Poonaga parpam 
   
S.No Parameter Observation Result 
1 Test for Sulphate Cloudy appearance 
present 
Positive 
2 Test for Chloride - Negative 
3 Test For Phosphate - Negative 
4 Test For Carbonate Cloudy appearance was 
evolved. 
Positive 
5 Test For Nitrate - Negative 
6 Test for Sulphide - Negative 
7 Test For Fluride & 
oxalate 
- Negative 
8 Test For Nitrite - Negative 
9 Test For Borate - Negative 
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Miscellaneous 
 
S.No Parameter Observation Result 
1 Test for starch - Negative 
2 Test for reducing sugar - Negative 
3 Test for alkaloids - Negative 
S.No Parameter Observation Result 
1 Test for Lead - Negative 
2 Test for Copper - Negative 
3 Test For Aluminium - Negative 
4 Test For Iron Mild  Red colour 
appeared 
Positive 
5 Test For Zinc - Negative 
6 Test for Calcium Cloudy appearance and 
white precipitate was 
formed 
Positive 
7 Test For Magnesium - Negative 
8 Test For Ammonium - Negative 
9 Test For Potassium - Negative 
10 Test For Sodium - Negative 
11 Test For Mercury - Negative 
12 Test For Arsenic - Negative 
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4 Test for tannic acid - Negative 
5 Test for unsaturated 
compound 
- Negative 
6 Test for amino acid - Negative 
  
The result of preliminary chemical analysis reveals that the trail drug Poonaga 
parpam has Silicate, Copper, Sulphate, Carbonate, Iron, Calcium. 
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5.2.4. FTIR 
Fourier Transform Infra-Red Spectroscopy (FTIR) analysis results in 
absorption spectra provide information about the functional group and molecular 
structure of a material.  
IR relates with the sample and the bonds among atoms in the molecule stretch 
and bend, absorbing infrared energy and creating the infrared spectrum. It is of two 
kinds bending and stretching. FT-IR is a very useful tool in the recognition of the 
functional groups of bio molecules, thus aiding in their structural elucidation, so 
confirming the presence of active molecules responsible for the therapeutic activity of 
Siddha drugs. 
Fig.No.7 Poonaga parpam has following functional groups. 
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Table 5 INTERPRETATION OF FTIR SPECTRUM 
Wave number 
(cm-1)  
Vibrational  modes of 
Poonaga parpam in IR region  
Functional groups  
3403 O-H Stretch Alcohol 
3009 C-H Stretch Aromatic 
2924 C-H Stretch Alkane 
1744 C=O Stretch Carbonyl 
1713 Acyclic Stretch Ketone 
1460 -C-H Bending Alkane 
1377 -C-H Bending Alkane 
1255 C-N Stretch Amine 
1166 C-F Stretch Alkyl halide 
720 C-Cl Stretch Alkyl halide 
 
 In the FT-IR Spectra analysis, this Poonaga Parpam sample exhibits the peak 
value shows in Table 5 at the wave number of 3403, 3009, 2924, 1744, 1713, 
1460, 1377, 1255, 1166,720 having O-H stretch, C-H stretch, C=O stretch, 
acyclic stretch, -C-H bending, C-N stretch, C-F stretch, C-Cl stretch.  
 This indicates the presence of some organic functional groups such as alcohol, 
aromatic, alkane, carbonyl, ketone, alkane, amine and alkyl halide.  
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 Stretching and bending modes of Poonaga Parpam shows the vibrational 
frequencies in the IR region. It confirms the dipole moment of the sample. 
 From the observed FTIR Spectra the presence of some organic compounds are 
identified such as copper phosphate, potassium bicarbonate, copper selenite, 
ammonium thiosulfate, ammonium chloride, ammonium sulfate, ammonium 
chromate, sodium selenate and zinc chromate. 
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5.2.5. ICP-OES(INDUCTIVELY COUPLED PLASMA OPTIC EMISSION 
SPECTROMETRY)  
The drug (Poonaga Parpam) sample was analysed by the Inductively Coupled 
Plasma Optical Emission Spectroscopy (ICP-OES) to detect the trace elements and 
other elements quantitatively. The result of ICP-OES is given in the Table.No.6. 
 
Table 6: ICP-OES of Poonaga Parpam 
S.NO Elements Wavelength (nm) Poonaga  parpam 
  ( 0.37010g) 
1.  Al 396.152 BDL 
2.  As 188.979 BDL 
3.  Ca 315.807 12.080 mg/L 
4.  Cd 228.802 BDL 
5.  Cu 27.393 21.561 mg/L 
6.  Fe 238.204 01.306 mg/L 
7.  Hg 253.652 BDL 
8.  K 766.491 03.021 mg/L 
9.  Mg 285.213 01.204 mg/L 
10.  Na 589.592 01.300 mg/L 
11.  Ni 231.604 BDL 
12.  Pb 220.353 BDL 
13.  P 213.617 16.381 mg/L 
14.  S 180.731 01.204 mg/L 
 
 BDL: Below Detectable Limit 
1% = 10000ppm, 
1ppm = 1/1000000 or 1ppm = 0.0001% 
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The toxic metals and the permissible limits    
Heavy metals   WHO & FDA limits 
Arsenic (As)     3 ppm 
Mercury (Hg)     1ppm 
Lead (Pb)     10ppm 
Cadmium (Cd)    0.3ppm 
Interpretation: 
ICP-OES reveals high concentration of Cu in Poonaga parpam (21.561  mg/l). 
It also has physiologically important minerals like Ca, Fe, K, Mg, Na, P and S. From 
the above results, the heavy metals such as Arsenic, Cadmium, Lead, Mercury were 
observed as BDL and those are within the WHO permissible limits. Hence the safety 
of the drug Poonaga parpam is ensured for clinical use.  
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5.2.6. SEM (Scanning Electron Microscope with Energy Dispersive X-Ray 
Analysis):  
In addition, the particle size and chemical elements were assessed by Scanning 
Electron Microscope with Energy Dispersive X-Ray Analysis (SEM EDAX). SEM is 
one of the most widely used instruments in research areas. The SEM picture of 
Poonaga parpam is shown in Fig.No.8 
Fig.No.8. SEM image shows nano particles in Poonaga Parpam 
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EDAX 
Energy Dispersive X-Ray Analysis is used to find out elements present in the 
sample qualitatively in a smaller area which is selected. The results of EDAX is 
shown in Fig.No.9 and Table.No.7 
 
Fig.No.9 EDAX analysis of Poonaga Parpam 
Table.No.7: Representing the weight and atomic percentage of elements present 
in Poonaga Parpam 
 
Interpretation : 
The SEM imaging of the Poonaga Parpam shows that the particles are in nano 
size and have pores in it as shown in Fig 8. They are nano particles having a size of 
100 to 120 nm. The particles aggregate, and individual particles are seen on the top of 
the clusters. The particle size is low because of the grounding for more than 12 hours 
Element Weight % Atomic % Net Int. Error % 
Cu K 44.62 69.99 163.17 13.36 
S K 48.65 28.59 9323.94 1.26 
TcL 6.28 1.21 533.86 5.63 
K K 0.45 0.22 48.41 21.64 
    cu 
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and the particle aggregation is due to the calcination process. The extremely small 
size of nanoparticles allows them to penetrate cells and interact with cellular 
molecules.  
Nanoparticles have significant properties that can be used to enhance drug 
delivery. As the particle is in nano size, a low dose of the drug is enough to treat 
diseases. Hence Poonaga Parpam which is prepared biologically contains 
nanoparticles to enhance fast pharmacological action in target site. 
EDAX analysis shows the elements present in the sample as shown in Fig.9. 
The table represents the weight and atomic percentage of sample. The quantitative 
estimation of copper and Sulphur in the test drug Poonaga Parpam  is 44.62 Wt % 
and 48.65  Wt% respectively which may be due to the presence of earthworms. The 
presence of Tc and K is very small which may be contributed by the presence of 
extract of aduthinna paalai in the sample.  
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5.2.7. (XRD) X-RAY DIFFRACTOMETRY 
 XRD is an essential tool for analyzing important physical parameters like 
crystalline structure, grain size, etc., 
 
Fig.No.10 XRD image of Poonaga parpam 
 The X-Ray Diffraction pattern of the Drug Poonaga Parpam reveals the 
presence of major peak with two theta value of 27.12 with the intensity of 
3250. 
 Major peaks observed in test sample with two theta values of 27.12 and their 
corresponding intensities matching with the material copper. 
 The X-Ray Diffraction pattern of the test drug Poonaga Parpam reveals the 
presence of major peak with two theta value of 32.30 with the intensity of 
3100 corresponds to iron. 
 Further from this observation it was concluded that copper and iron may the 
key ingredients present in the test drug Poonaga Parpam. 
 
RESULTS 
 
STANDARDIZATION AND PHARMACOLOGICAL SCREENING OF “POONAGA PARPAM ” Page 88 
 
5.2.8. THERMOGRAVIMETRIC ANALYSIS (TGA):  
 
 
Fig.No.11 Thermal chemical characterization of Poonaaga parpam  
 Thermo Gravimetric Analysis of Poonaga Parpam carried out at the 
maximum of 1300 degree centigrade. The main objective of the study is to 
evaluate the decomposition and stability limit of the test drug Poonaga 
Parpam. 
 The test drug Poonaga Parpam seems to be stable at the temperature varying 
from 100°C to 380°C. 
 Point of decomposition begins when the temperature increases beyond 400°C. 
 Weight of the final residual matter was observed with 48.70 % of residual 
volume. 
 From the result of the present investigation it was concluded that the test drug 
Poonaga Parpam seems to be stable at varying temperature ranges from 50 to 
400°C.  
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6. PHARMACOLOGICAL STUDIES 
6.1. EVALUATION OF BRONCHODILATOR ACTIVITY OF POONAGA 
PARPAM USING HISTAMINE INDUCED BRONCHO CONSTRICTION IN 
GUINEA PIG 
Table.No.8: Effect of Poonaga Parpam against Histamine induced 
bronchoconstriction in guinea pig 
 
Groups Onset of Convulsion  in 
sec. 
% protection 
 
               Group-I   
Vehicle Control- Honey (p.o) 
 
93.75±0.39 
 
-- 
 
Group-II  Standard 
(Chlopheniramine maleate – 
2mg/kg, i.p.) 
 
 
 
994.51±0.44** 
 
 
100 
 
Group-III Poonaga parpam 
(100mg/kg, p.o) 
 
 
280.66±.0.22 ** 
 
29 
 
Group-IV Poonaga parpam 
(200mg/kg, p.o) 
 
 
632.10±0.22** 
 
64 
 
The results were expressed as mean ± SD and was analyzed statistically using one 
way ANOVA followed by Dunnett’s multiple comparisons test.  
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Chart.No.1: Bronchodilator effect of Poonaga Parpam in Guinea pig 
  
Histamine induced broncho-constriction is the traditional immunological 
model of antigen induced airway obstruction. Histamine when inhaled causes hypoxia 
and leads to convulsion in the guinea pigs and causes very strong smooth muscle 
contraction, profound hypotension, and capillary dilation in the cardiovascular 
system. A prominent effect caused by histamine is severe bronchoconstriction in the 
guinea pigs that causes asphyxia and death. Bronchodilators can delay the occurrence 
of these symptoms. 
Poonaga parpam significantly (p<0.01) and dose dependently increased the 
time of PCT following exposure to histamine aerosols induced bronchospasm in 
guinea pigs. The percentage protection was found to be 64% in 200 mg/kg of 
Poonaga parpam treated animals, when compared with the untreated control group. 
The standard group also significantly (p<0.01) delayed the onset of pre convulsive  
dyspnoea time and the percentage protection was found to be 100%, when compared 
with untreated control group. 
The study resulted in deep-rooted the bronchodilator properties of the trial 
drug Poonaga parpam justifying its claiming in the treatment of asthma. 
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6.2. EVALUATION OF ANTI-INFLAMMATORY ACTIVITY OF POONAGA 
PARPAM IN WISTAR ALBINO RATS 
Table 9 :  Inhibitory effect of Poonaga Parpam against carrageenan induced paw 
oedema in Wistar albino rats. 
   
Groups  Percentage of inflammation after carrageenan injection at 
different hrs 
0 hr 1 hr 2 hrs 3 hrs 
 
Group-I  
Vehicle Control- 
Honey (p.o) 
 
0.89±0.05 
 
1.18±0.04  
 
1.51±0.05 
 
1.65±0.04 
 
Group-II  
Standard 
Indomethacin  
10 mg/kg(p.o) 
 
0.91±0.22 
 
1.03±0.04    
 
 
1.12±0.07    
 
1.17±0.07    
 
 
Group-III  
Poonaga Parpam            
12 mg/kg(p.o) 
 
0.90±0.06 
 
1.15±0.05 
 
1.30±0.06    
 
1.39±0.05    
 
Group-IV  
Poonaga Parpam 
24 mg/kg(p.o) 
 
0.93±0.05 
 
1.13±0.05 
 
1.23±0.05    
 
1.29±0.05    
 
Values are Mean ± SD; n = 6 animals in each group: 
* 
P<0.05, 
**
 P< 0.01, 
***
P<0.001 
is considered significant when compared with control rats and followed by one way 
ANOVA. 
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Chart.No.2. Anti inflammatory effect of Poonaga Parpam in Wistar albino rats 
 
      
The anti-inflammatory activity was evaluated using carrageenan-induced paw 
edema models in Wistar albino rats. Oedema formation in the carrageenan-induced 
paw edema model is a biphasic response. In the early hyperemia, 0-2 hrs after 
carrageenan injection, there is a release of histamine, serotonin and bradykinin on 
vascular permeability. The inflammatory edema reached its maximum level at 1 hr 
and after that, it started declining. The late phase of the inflammatory response has 
been shown to be due to potentiating effect of bradykinin on mediator release and 
prostaglandins, producing edema after mobilization of the leukocytes. Nitrous oxide 
(NO) is a potent vasodilator and is also involved in carrageenan-induced edema, 
which may be related to its ability to increase vascular permeability and edema 
through changes in local blood flow. 
The effect of Poonaga parpam on carrageenan-induced rat paw edema at 
different hours of study was compared to that of control for the evaluation of anti-
inflammatory activity on the basis of percent inhibition of paw edema volume. The 
Group I is carrageenan induced along with oral administration of vehicle honey which 
showed an elevated level of paw volume in each hour. At the end of the 3
rd
 hour the 
paw volume is higher than the Initial Paw Volume. In Group II the Standard 
Indomethacin is orally received which gives low paw volume in each hour (1st to 3
rd
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hr). Finally at the end of 3rd hour paw volume shows least value. In Group III & IV 
the Carrageenan is subcutaneously induced along with the oral administration of 
Poonaga parpam of 12 mg/kg and 24 mg/ kg respectively. The anti-inflammatory 
activity was found to be dose dependent in carrageenan-induced paw edema model. 
Poonaga parpam has shown significant (P < 0.001) inhibition of paw oedema on 3
rd
  
hour at the doses of 12 and 24 mg/kg, respectively.
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6.3 EVALUATION OF ANTI-PYRETIC ACTIVITY OF POONAGA PARPAM 
IN WISTAR ALBINO RATS 
 
Table. 10 Antipyretic effect of Poonaga Parpam in Wistar albino rats by 
Brewer’s yeast induced pyrexia. 
 
Groups 
 
Initial 
Rectal 
temp.in °c  
Rectal temp.in °c after 8 hrs of yeast injection 
0hr 
 
1hrs 
 
2hrs 
 
3hrs 
 
GroupI   
Control 
Honey (p.o) 
    
36.97±0.27 39.77±0.23 39.97±0.23 40.10±0.10 40.37±0.15 
Group-II  
Standard 
Paracetamol 
150mg/kg 
p.o 
36.50±0.21 40.10±0.21 39.27±0.24*** 38.20±0.18*** 37.13±0.21*** 
Group-III 
Poonaga 
Parpam           
12mg/kg p.o 
36.90±0.28 40.37±0.32 40.10±0.30 39.23±0.46*** 38.33±0.21*** 
Group-IV 
Poonaga 
Parpam 
24mg/kg p.o 
36.73±0.41 40.20±0.33 39.80±0.40 38.40±0.38*** 37.50±0.21*** 
 
 
Values are Mean ± SD; n = 6 animals in each group: 
* 
P<0.05, 
**
 P< 0.01, 
***
P<0.001 
is considered significant when compared with control rats and followed by one way 
ANOVA. 
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Chart.No.3.Antipyretic effect of Poonaga Parpam in Wistar albino rats 
 
 
 
Antipyretic activity of Poonaga  parpam were evaluated using Brewer’s yeast-
induced hyperpyrexia in rats. The subcutaneous injection of yeast suspension 
markedly elevated the rectal temperature at the 8
th
 hour after administration. The 
results obtained from the study showed that there was significant increase in the body 
temperature of rats injected with Brewer’s yeast. The antipyretic effect started as early 
as the first hour after administration, and the effect was maintained for three hours 
after its administration. 
 Rats treated with the standard drug Paracetamol (150 mg/kg) has shown 
maximum reduction in rectal temperature during 3
rd
 hour after injection of Brewer’s 
yeast. It was found that Poonaga parpam at doses of 12 mg/kg and 24 mg/kg caused 
significant lowering of body temperature when compared to the control group 
animals. Inhibition of prostaglandin synthesis could be the possible mechanism of anti 
pyretic action as that of paracetamol. Also, there are several mediators or 
multiprocesses underlining the pathogenesis of fever. Inhibition of any of these 
mediators may bring about anti pyretic activity. 
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8. DISCUSSION 
The trial drug Poonaga parpam was selected from the text “Sikicha Rathina 
Deepam” for Standardization and screening the pharmacological effect of 
Bronchodilator, Anti inflammatory and Anti pyretic activities 
The drug was prepared as per the procedure and subjected to various studies to 
reveal its potency and effectiveness against the disease.  
Various collections of Siddha and Modern science about the ingredients of the 
drug supported the fact of Bronchodilator activity. Poonaga  parpam  had been 
subjected to various studies and it confirms the literature evidences. Literary 
collections, Chemical analysis, Elemental analysis and Pharmacological studies were 
done to prove the Bronchodilator, Anti inflammatory and Anti pyretic activities of 
Poonaga  parpam.  
Literary review about the ingredients of Poonaga Parpam from various text 
books give hope about its activity. The studies strongly substantiated textual 
references and as discussed below. 
Literary collections: 
Literary collections include drug review, which consist of Botanical aspect, 
Zoological aspect, Gunapadam aspect, pharmaceutical and pharmacological aspects 
which support this study. 
Drug review: 
 Botanical aspect: 
Drug review about the ingredients of Poonaga parpam from various text 
books were done. Botanical aspect deals with the identification, description, ethno 
medical important of the plants.  
Gunapadam aspect: 
Basically siddha medicines have five unique properties. They are 
 Suvai (Taste) 
 Gunam (Properties) 
 Veeriyam (Potency) 
 Pirivu (Class) 
 Mahimai (Action) 
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All the five properties are based on the Panchabootham (Five elements) 
present in the drug. According to our literature, derangement of Kaba causes Kodiya 
Kaasam 
             “கபமல்லாது காச சுவாசம் வாராது” 
 
The therapeutic potency of any drug were designed depending on the 
following parameters namely 
 Suvai 
 Gunam 
 Veeriyam 
 Vibhaham 
In Siddha system of medicine there is an interrelation between veeriyam and 
treatment.  Veppa Veeriyam normalizes the Kaba kutram. 
The ingredients of Poonaga parpam are Poonagam (earthworm) and 
Aaduthinnapaalai (Aristolochia bracteata). 
 Poonagam has Veppa Veeriyam and Stimulant action 
 Aaduthinnapaalai has Veppa Veeriyam and Stimulant action  
 
Majority of the ingredients of Poonaga parpam possesses  Veppa Veeriyam 
and Stimulant action. Sembu sathu which is present enormously in Poonagam  also 
posseses Veppa Veeriyam and Stimulant action. Hence it normalize the Kaba kutram. 
So the selected drug acts as a Bronchodilator. 
These collections showed the effectiveness of Poonaga Parpam in Bronchial 
asthma. 
 
Physico-chemical analysis 
 The trial drug Poonaga  parpam showed that the Loss on drying (LOD) was 
less than 1% which reveals the low moisture content present in the prepared 
medicine. Low moisture content- drug could get maximum stability and better 
shelf life.  
 The trial drug is found to have  total ash value 24.72% , whereas the acid 
insoluble ash and water soluble ash was 0.72% and 6.94%  respectively. The 
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value of total ash in the formulation is high because of the presence of  
inorganic ingredients and the method of preparation of this drug is calcination 
procedure.  
 pH of the trial drug was 8.4. It shows the alkalinity of the drug. 
Chemical analysis: 
Chemical analysis of the drug Poonaga Parpam revealed the presence of 
Silicate, Copper, Sulphate, Carbonate, Iron and Calcium. 
Instrumental analysis: 
Based on the results, Poonaga Parpam is preferably non-toxic to human in its 
therapeutic dose. The standardization of the drug was evaluated by chemical 
characterization with heavy metal analysis, functional group analysis, elemental 
analysis, thermal analysis and determination of particle size by ICP-OES, FTIR, 
XRD, TGA and SEM EDAX respectively.  
 ICP-OES reveals high concentration of Cu in Poonaga parpam (21.561  mg/l). 
It also has physiologically important minerals like Ca, Fe, K, Mg, Na, P and S. 
In Poonaga parpam , the heavy metals like As, Cd, Pb, Hg and trace element 
like Ni were below detectable level. This reveals the safety of the drug. 
 The FTIR results showed the presence of O-H stretch, C-H stretch, C=O 
stretch, acyclic stretch, -C-H bending, C-N stretch, C-F stretch, C-Cl stretch as 
functional groups. This indicates the presence of some organic functional 
groups such as alcohol, aromatic, alkane, carbonyl, ketone, alkane, amine and 
alkyl halide.  
 XRD results revealed that the copper and iron may be the key ingredients 
present in the test drug Poonaga Parpam. 
 TGA results revealed that the test drug Poonaga Parpam seems to be stable at 
varying temperature ranges from 50 to 400°C.  Point of decomposition begins 
when the temperature increases beyond 400°C. 
 The SEM picture shows that the particles are in nano size and have pores in 
the drug Poonaga Parpam. Further, the study shows that Poonaga Parpam is 
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a kind of nano medicine which favours the advantages of bio availability, 
better absorption and non toxic with minimal dose level. 
The chemical analysis and elemental analysis shows the presence of Cu as a 
major compound.  
PHARMACOLOGICAL STUDIES:  
The pharmacological activities like Bronchodilator, Anti inflammatory and 
Anti pyretic activity of Poonaga parpam shows significant effect. 
BRONCHODILATOR ACTIVITY  
The Bronchodilator activity of the Poonaga Parpam has been estimated in the 
Histamine induced bronchoconstriction in guinea pig. Increase in the Pre convulsive 
time (PCT) and increase in the percentage protection are the important criteria for the 
test drug in the management of asthma. Poonaga Parpam at the dose of 100 mg/kg, 
200 mg/kg significantly and dose dependently increased the time of PCT compared 
with Chlopheniramine maleate – 2mg/kg treated Group. Experimental groups (III- IV) 
were compared with control group. Values are statistically significant at P<0.01. 
 
ANTI-INFLAMMATORY ACTIVITY 
The anti-inflammatory activity was evaluated using carrageenan-induced paw 
edema models in Wistar albino rats. The anti-inflammatory activity was found to be 
dose dependent in carrageenan-induced paw edema model. Poonaga Parpam has 
shown significant (P < 0.001) inhibition of paw oedema on 3
rd
  hour at the doses of 12 
and 24 mg/kg, respectively.                                                    
 
ANTI-PYRETIC ACTIVITY  
The Anti pyretic activity of the Poonaga parpam has been estimated rats by 
Brewer’s yeast induced pyrexia in Wistar albino rats. The result indicates that 
Poonaga parpam at doses of 12 mg/kg and 24 mg/kg  caused significant lowering of 
body temperature when compared to the control group animals. Values are 
statistically significant at P<0.001. 
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9.SUMMARY 
 The test drug Poonaga Parpam , a traditional Siddha formulation was selected 
from the classical siddha literature Sikicha Rathina Deepam for its 
Bronchodilator, Anti inflammatory and Anti pyretic activities 
 The test drug was prepared as per the Standard operative procedure mentioned 
in Siddha literature. All the ingredients were identified and authenticated by 
the experts. 
 Review of Literature in various categories was carried out. Siddha aspect, 
botanical aspect, Zoological aspect, Pharmaceutical and pharmacological 
review disclosed about the drug and the disease.  
 The drug was subjected to analysis such as physicochemical, chemical, 
instrumental and pharmacological analysis. 
 Chemical analysis of the drug Poonaga Parpam revealed the presence of 
Silicate, Copper, Sulphate, Carbonate, Iron, Calcium. 
 The presence of organic functional groups such as alcohol, aromatic, alkane, 
carbonyl, ketone, alkane, amine and alkyl halide were identified in Poonaga 
Parpam by using Fourier Transform Infra-Red Spectroscopy (FTIR). 
 The presence of heavy metals in Poonaga Parpam were identified within the 
WHO permissible limits by using Inductively Coupled Plasma Optical 
Emission Spectroscopy (ICP-OES) 
 The particle size and Identification and quantitative analysis of chemical 
elements were assessed by Scanning Electron Microscope with Energy 
Dispersive X-Ray Analysis (SEM with EDAX). The SEM analysis of 
Poonaga Parpam reveals that the majority of the particles are nano in size. 
 Characterization and Identification of crystalline materials were assessed by 
X-Ray Diffractometer (XRD). The particles of Poonaga Parpam shows some 
crystallinity in nature. 
 The thermal analysis of Poonaga Parpam by Thermogravimetric analysis or 
thermal gravimetric analysis (TGA). Point of decomposition begins in the 
sample Poonaga Parpam when the temperature increases beyond 400°C. 
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 Pharmacological studies were done. It revealed that the drug Poonaga Parpam 
possess Bronchodilator, Anti-inflammatory and Anti pyretic activities in 
animal model. 
 From the results and statistical analysis it was proved that the drug Poonaga 
Parpam has  
1. Bronchodilator activity  
2. Anti-inflammatory activity  
3. Anti pyretic activity  
 
 This present study suggests Poonaga Parpam has remarkable medicinal value 
in the treatment of Bronchial Asthma. Thus the Siddha formulation Poonaga 
Parpam is Standardized and validated for its efficacy in treating Bronchial 
asthma (Kaasam) and it would be a great drug of choice. 
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10. CONCLUSION 
 
From the Literature evidence, Physico chemical analysis, chemical 
analysis, Elemental analysis and Pharmacological studies, the drug Poonaga Parpam 
have potent Bronchodilator, Anti-inflammatory and Anti pyretic activity. It was 
concluded that the Poonaga Parpam can be used in the management of Kaasam 
(Bronchial asthma). 
Future scope 
The pharmacological activities carried out in animals for Bronchodilator 
activity supported the study. But to evaluate the drug Poonaga Parpam in a better 
way, clinical research is required so that the exact benefit and aim of the study would 
be fulfilled and a good drug to fill the space for an effective anti asthmatic drug would 
be achieved. Although SEM depicted the presence of nano particles, the active 
compound exhibiting the therapeutic efficacy should be analysed.  If these lacunas are 
corrected the Poonaga Parpam would be proficient with the new hope in the 
treatment of Bronchial asthma.  
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